Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.858527462712915e-37,19.19906610474664,1598.7092234080326,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.7996242143429546e-34,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.6638840594352054e-31,13.96405777628485,989.6465043275391,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC2', 'SDHC', 'NDUFC1', 'SDHD', 'COX6B1', 'COX7A2L', 'SCO1', 'NDUFS6', 'NDUFS5', 'NDUFS1', 'UQCRC2', 'SLC25A5', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'COX15', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'COX11', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",4.608958844635519e-29,0,0,66
3,Oxidative phosphorylation WP623,2.0214222596105572e-17,12.190024712479802,468.5863202845804,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'ATP5PO', 'NDUFS1']",3.732893106080829e-15,0,0,37
4,Nonalcoholic fatty liver disease WP4396,8.776695928497154e-16,4.305790079631584,149.27856210146797,"['GSK3B', 'NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'IRS1', 'COX4I1', 'PRKAG1', 'PIK3CD', 'COX6A1', 'COX7C', 'AKT3', 'UQCRFS1', 'RAC1', 'NDUFC2', 'SDHC', 'NDUFC1', 'SDHD', 'COX6B1', 'COX7A2L', 'PIK3CA', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS1', 'UQCRC2', 'ATF4', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'PIK3R3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'UQCRH', 'CDC42', 'NDUFV3', 'NDUFV1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'EIF2AK3', 'NDUFA1', 'COX6C', 'EIF2S1', 'NFKB1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",1.215572386096856e-13,0,0,65
5,Mitochondrial complex I assembly model OXPHOS system WP4324,8.72077157585707e-14,8.939730310728942,268.8220135580984,"['NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'DMAC2', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'ECSIT', 'TMEM186', 'FOXRED1', 'NDUFV3', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS1', 'TMEM126B']",9.662614906049633e-12,0,0,33
6,Mitochondrial CIV Assembly WP4922,3.7685262313722773e-10,10.099900695134062,219.15943110933563,"['COA3', 'COX7B', 'COX16', 'PET100', 'COX15', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'PNKD', 'COX11', 'COX14', 'SMIM20']",3.479605886967069e-08,0,0,22
7,Base Excision Repair WP4752,1.2875375972005602e-05,5.23479163717023,58.944768913672384,"['FEN1', 'PARP1', 'MPG', 'APEX2', 'LIG3', 'HMGB1', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'POLD1', 'APEX1', 'POLD2', 'POLE3', 'POLL', 'POLE']",0.0010189940412130146,0,0,16
8,Cellular Proteostasis WP4918,3.3676157794985866e-05,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.002332073927302771,0,0,6
9,Mitochondrial complex III assembly WP4921,0.00034077097896768237,6.858767303889255,54.76245525114858,"['UQCRB', 'UQCC2', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRC2', 'UQCRH']",0.020976346927566225,0,0,9
10,Translation Factors WP107,0.0008782536025474033,2.718801669973545,19.13377111080087,"['EIF2B2', 'EIF2AK1', 'EIF2AK3', 'EIF2S2', 'EIF2S1', 'EIF1', 'EEF1B2', 'EEF1A1', 'EIF5', 'EIF2S3', 'EIF6', 'EIF3I', 'EIF3J', 'EIF4H', 'ETF1', 'EIF3F', 'EIF3D', 'EIF4G3', 'EIF4B']",0.048655249581126145,0,0,19
11,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0011698540790145181,5.143333882663151,34.72201058896483,"['EIF5', 'EIF2S3', 'EIF3I', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF2S1', 'EIF3D', 'EIF1']",0.058918105434003915,0,0,9
12,Pyrimidine metabolism WP4022,0.0018347697921913357,2.1272195653203276,13.403262168433558,"['PRIM2', 'POLD4', 'ZNRD1', 'POLD1', 'POLR2D', 'TWISTNB', 'POLD2', 'POLR2E', 'TK2', 'POLR2G', 'POLR2I', 'POLE', 'POLR2J', 'POLR2K', 'POLR2L', 'DUT', 'POLR3GL', 'NME2', 'NME1', 'DCTD', 'POLE4', 'POLR3D', 'POLE3', 'POLR1E', 'DCTPP1', 'POLR3K']",0.08470520540616666,0,0,26
13,7q11.23 copy number variation syndrome WP4932,0.002812623519442551,1.9542087903509113,11.478314218296326,"['BECN1', 'ELN', 'ATP5MC2', 'ATP5MC3', 'DDX21', 'ACACB', 'ACACA', 'ATP5MC1', 'GRIP1', 'ATP5F1A', 'ATP5F1B', 'CFL1', 'EIF4H', 'RFC2', 'ATP5PB', 'EIF2AK3', 'NRG1', 'ATP5F1E', 'CLIP2', 'MYBBP1A', 'DNAJC30', 'ATP5PO', 'SQSTM1', 'DLD', 'STX1A', 'VAMP2', 'ATF4', 'FBN1', 'ATPAF1']",0.11986103305932101,0,0,29
14,Ciliary landscape WP4352,0.005111000145155716,1.549253349807213,8.174418669394049,"['MYL6B', 'MCM10', 'RPGR', 'PSMD8', 'PSMD7', 'ARHGDIA', 'NEFL', 'BBS9', 'CEP170', 'RAC1', 'RAB8A', 'BBS4', 'RAB2A', 'NUDC', 'CNOT6L', 'IFT140', 'DYNLT3', 'DYNLL1', 'DYNLL2', 'AFG3L2', 'TBC1D4', 'TIPRL', 'MCM4', 'EFHC2', 'PAFAH1B1', 'ECHS1', 'PSMD13', 'CAMK2A', 'COPS7B', 'COPS7A', 'EXOSC7', 'RMND5B', 'PGRMC2', 'EXOSC4', 'SNRPB2', 'DCAF11', 'NDUFA5', 'EXOC6B', 'COX6C', 'LSM4', 'NFKB1', 'AIMP1', 'COPS4', 'IFT20', 'MKLN1', 'COPS3', 'IFT22', 'RAB14', 'MFAP1', 'WNK1', 'IFT27', 'COPS8', 'CALM2']",0.20224957717259046,0,0,53
15,DNA Repair Pathways Full Network WP4946,0.0055891953898847095,1.7583597311287955,9.120471150353389,"['FEN1', 'MPG', 'CETN2', 'HMGB1', 'POLD4', 'RAP1A', 'NTHL1', 'POLD1', 'CHEK1', 'POLD2', 'REV3L', 'POLL', 'POLE', 'XRCC6', 'PARP1', 'CENPX', 'RFC2', 'REV1', 'RPA2', 'APEX2', 'LIG3', 'FANCC', 'RAD23A', 'GTF2H3', 'GTF2H5', 'RBX1', 'FANCF', 'DDB1', 'POLE4', 'NEIL2', 'APEX1', 'ERCC2', 'POLE3']",0.20642761639974191,0,0,33
16,VEGFA-VEGFR2 Signaling Pathway WP3888,0.006446510863466466,1.3691151811848103,6.906113039498245,"['ITGB1', 'YWHAE', 'RPL5', 'GSK3B', 'CCDC124', 'ARPC5L', 'SRP54', 'HMGB1', 'RPL10A', 'SLC8A1', 'RPL7', 'ACTG1', 'RND1', 'TUBB8', 'RPS6KA5', 'PSMD4', 'RPL18A', 'TMSB4X', 'CFL1', 'RACK1', 'RPLP2', 'ITGAV', 'ELOC', 'RAC1', 'ATP6V1E1', 'TMSB10', 'ACP1', 'HRAS', 'MAP2K4', 'HSP90AA1', 'SSR4', 'PRKCB', 'TPM3', 'PRKCD', 'SSR3', 'GAB1', 'SARS', 'RPL13A', 'ADAM10', 'PDIA6', 'RHOA', 'INPP4B', 'PIK3CA', 'FSCN1', 'MYH9', 'RPL27', 'RPL26', 'ALDOA', 'SLC25A11', 'ATF4', 'NAPA', 'LRRC59', 'SET', 'EPB41', 'NOTCH4', 'PXN', 'CRIP2', 'TXN', 'ACACB', 'NDRG1', 'ACACA', 'CAMKK2', 'CDC42', 'STIP1', 'RAP1A', 'AP2S1', 'PGK1', 'RICTOR', 'ASCC3', 'ZC3H15', 'TXNDC5', 'DECR1', 'SDF2L1', 'STAT1', 'SIAH2', 'IDH2', 'EIF2AK3', 'PDE4DIP', 'NFKB1', 'DNAJA1', 'NFKBIA', 'AFDN', 'CYCS', 'HYOU1', 'TPP1', 'P4HB', 'EIF3F', 'CALR', 'GRSF1', 'RAB5A', 'EIF3D', 'EIF4G2']",0.22321043864752638,0,0,92
17,Nucleotide Excision Repair WP4753,0.007754097718950911,2.365849769963103,11.496927011388916,"['RFC2', 'CETN2', 'RPA2', 'RAD23A', 'GTF2H3', 'GTF2H5', 'RBX1', 'POLE4', 'DDB1', 'POLD4', 'POLD1', 'POLD2', 'ERCC2', 'POLE3', 'POLE']",0.2524574194303934,0,0,15
18,Photodynamic therapy-induced unfolded protein response WP3613,0.008202587634922529,3.0473678426200683,14.637439051928544,"['NARS', 'XBP1', 'WARS', 'DDIT3', 'DNAJB11', 'EIF2AK3', 'CALR', 'PDIA6', 'HSP90B1', 'ATF4']",0.2524574194303934,0,0,10
19,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.012098701241814436,2.212894703200239,9.769171462466648,"['PPP1R16B', 'XBP1', 'PPP1R11', 'EIF2AK1', 'EIF2AK3', 'EIF2S1', 'PPP1R2', 'MAP1LC3A', 'PPP1R1A', 'PPP1R7', 'PPP1R3E', 'DDIT3', 'PPP1R8', 'PPP1R12C', 'ATF4']",0.34406846152258386,0,0,15
20,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.012421244098288226,5.708936800526662,25.052795901855017,"['MESP2', 'HES7', 'EPHA4', 'RIPPLY2', 'DLL3']",0.34406846152258386,0,0,5
21,Proteasome Degradation WP183,0.013261615015621606,2.0083370288248337,8.681802998900578,"['UBE2B', 'H2AFZ', 'PSMD13', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMD4', 'PSMA1', 'PSMB2', 'PSMA2', 'PSMB3', 'PSME3', 'PSMC1', 'PSME1', 'PSME2']",0.34985403422163663,0,0,18
22,16p11.2 proximal deletion syndrome WP4949,0.014252935033116814,1.9063568199360459,8.103527131894255,"['CCT3', 'IGBP1', 'INO80E', 'PRRT2', 'DOC2A', 'PTEN', 'KIF22', 'NR3C1', 'SEZ6L2', 'NFKB1', 'PPP2CB', 'HIRIP3', 'ASPHD1', 'PPP4R4', 'KCTD13', 'CCDC6', 'PPARG', 'ALDOA', 'CDIPT', 'CCT4']",0.3589148185612144,0,0,20
23,Ras signaling WP4223,0.015874016913697175,1.5272505272505272,6.3275083814742255,"['RAB5C', 'PIK3R3', 'PIK3CD', 'RASAL2', 'PLA2G6', 'STK4', 'IGF1R', 'CDC42', 'RASSF1', 'GNG10', 'GNG3', 'RAP1A', 'RRAS', 'AKT3', 'ABL2', 'RAC1', 'IKBKG', 'PRKACA', 'HRAS', 'PDGFRB', 'PRKCG', 'PRKCB', 'PLA2G4C', 'GAB1', 'NFKB1', 'RHOA', 'MAPK10', 'AFDN', 'ZAP70', 'MRAS', 'PIK3CA', 'GNB1', 'CALM3', 'GNB5', 'RGL1', 'SOS1', 'RAPGEF5', 'CALM2', 'RAB5A', 'SOS2']",0.3823567552255754,0,0,40
24,Cori Cycle WP1946,0.018213786900207352,3.9151418222870316,15.682399880529509,"['G6PD', 'TPI1', 'PGK1', 'TALDO1', 'ALDOA', 'PFKP']",0.4178190474786452,0,0,6
25,Canonical and non-canonical Notch signaling WP3845,0.018952365185901102,2.741727092946605,10.873214079750404,"['MAML2', 'HEY1', 'RRAS', 'MFAP1', 'NOTCH4', 'PSEN2', 'ADAM10', 'DLL3', 'DLK2']",0.4178190474786452,0,0,9
26,Non-small cell lung cancer WP4255,0.019608836163257717,1.8298379093615613,7.194510927197155,"['PRKCG', 'PRKCB', 'GADD45A', 'PIK3CD', 'PIK3R3', 'TGFA', 'BRAF', 'STK4', 'RXRB', 'RASSF1', 'PIK3CA', 'AKT3', 'E2F1', 'CYCS', 'BAX', 'SOS1', 'JAK3', 'HRAS', 'SOS2', 'PDK1']",0.4178190474786452,0,0,20
27,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.027620596398315166,2.0000206338725652,7.178461135455282,"['MAP2K4', 'CSNK2A1', 'PRKCD', 'PIK3R3', 'MAPK10', 'RPS6KA5', 'PIK3CA', 'RPS6KA2', 'AKT3', 'PIM2', 'PRKACA', 'EIF4G3', 'EIF4B', 'PDK1']",0.5667337186913557,0,0,14
28,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.030142973951657947,1.6772481518261062,5.8733933132392835,"['PRKCG', 'PDGFRB', 'GSK3B', 'PRKCB', 'PTEN', 'GAB1', 'PIK3CD', 'PIK3R3', 'TGFA', 'NRG1', 'BRAF', 'IGF1R', 'MRAS', 'PIK3CA', 'RRAS', 'AKT3', 'BAX', 'JAK2', 'EIF4E2', 'SOS1', 'HRAS', 'SOS2']",0.5956993815083579,0,0,22
29,Pathogenic Escherichia coli infection WP2272,0.031182819609643284,1.9048601937472478,6.605841787323402,"['ITGB1', 'ARPC5L', 'ARPC4', 'ARPC5', 'YWHAZ', 'RHOA', 'ACTG1', 'TUBB8', 'CDC42', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ARPC2', 'ARPC3', 'ARHGEF2']",0.5956993815083579,0,0,15
30,Chemokine signaling pathway WP3929,0.0341180446468997,1.5093350004238366,5.098426266580206,"['GSK3B', 'PXN', 'PIK3R3', 'PIK3CD', 'ADCY1', 'ADCY7', 'CDC42', 'GNG10', 'GNG3', 'RAP1A', 'AKT3', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'JAK3', 'VAV3', 'PRKCB', 'STAT1', 'PRKCD', 'BRAF', 'NFKB1', 'NFKBIA', 'ADCY9', 'PLCB4', 'PIK3CA', 'GNB1', 'GNB5', 'SOS1', 'SOS2', 'NFKBIB']",0.6231592985172533,0,0,31
31,Regulation of Microtubule Cytoskeleton WP2038,0.034869924646272296,1.9806050605060506,6.647169209055125,"['GSK3B', 'TRIO', 'PTEN', 'TESK2', 'CDC42', 'CLIP1', 'PIK3CA', 'DPYSL2', 'STMN1', 'RHO', 'CDK1', 'RAC1', 'PRKACA']",0.6231592985172533,0,0,13
32,mRNA Processing WP411,0.03770292339308778,1.4933389250017475,4.895191344554981,"['SF3B5', 'DHX8', 'RNMT', 'SRP54', 'CSTF2T', 'SNU13', 'SNRPD1', 'CLP1', 'CSTF1', 'SNRPB2', 'SNRPD3', 'TXNL4A', 'HNRNPA1', 'SF3A1', 'SNRPN', 'CPSF1', 'PRMT2', 'NCBP2', 'PTBP2', 'LSM2', 'PRPF4', 'LSM7', 'PHF5A', 'SNRPG', 'SNRPE', 'SREK1', 'CLASRP', 'DNAJC8', 'SNRPA', 'SNRPB', 'SRSF9']",0.6527318612428321,0,0,31
33,Mitochondrial CII Assembly WP4920,0.03957212153437579,4.565646594274432,14.74535108357148,"['SDHAF2', 'SDHAF1', 'SDHC', 'SDHD']",0.6643319796983087,0,0,4
34,DNA Mismatch Repair WP531,0.04139679184946186,2.436287753981329,7.75848477813325,"['POLE4', 'POLD4', 'RFC2', 'POLD1', 'POLD2', 'POLE3', 'RPA2', 'POLE']",0.6745241966059373,0,0,8
35,Mitochondrial fatty acid synthesis pathway WP4317,0.043568143786119166,6.847203947368421,21.455227710571325,"['MECR', 'MCAT', 'ACACA']",0.6786360487407923,0,0,3
36,DNA Replication WP466,0.04409909341997928,1.9584766932177027,6.113024744142104,"['PRIM2', 'POLD4', 'ORC6', 'ORC1', 'RFC2', 'POLD1', 'POLD2', 'RPA2', 'MCM4', 'MCM10', 'POLE', 'UBA52']",0.6786360487407923,0,0,12
37,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.04656826881022917,2.010474934036939,6.165796696930288,"['PRKCG', 'KISS1', 'PLCB4', 'STAR', 'PIK3CA', 'PRKCB', 'PRKCD', 'PIK3CD', 'HRAS', 'NFKB1', 'PDK1']",0.6972654302937017,0,0,11
38,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.04868743487569744,3.26154424903602,9.857477031835625,"['IL11', 'ZEB1', 'JAK2', 'JAK3', 'NFKB1']",0.7098115505562206,0,0,5
39,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.05261901523243669,2.2838550247116967,6.725217002972815,"['NFKBIA', 'GSK3B', 'ZAP70', 'PTEN', 'DYRK1A', 'CALM2', 'NFKB1', 'PDK1']",0.7385119182560491,0,0,8
40,Hippo-Yap signaling pathway WP4537,0.05332216016289163,2.4592581331711765,7.209077336573102,"['RASSF1', 'YWHAQ', 'NF2', 'TNIK', 'NDRG1', 'TEAD1', 'MAP4K3']",0.7385119182560491,0,0,7
41,G13 Signaling Pathway WP524,0.055882405371949176,1.9330094377917597,5.575776741868757,"['CDC42', 'GNA13', 'MAPK10', 'CYFIP1', 'PIK3CA', 'CFL1', 'PIK3CD', 'RAC1', 'CALM2', 'MAP3K4', 'RHOA']",0.7550939652697523,0,0,11
42,Myometrial relaxation and contraction pathways WP289,0.060666541298518624,1.4076590961346855,3.9447716931329233,"['YWHAE', 'RYR2', 'YWHAB', 'CAMK2A', 'ITPR2', 'ADCY1', 'ADCY7', 'SLC8A1', 'ACTG1', 'RGS4', 'GNG3', 'YWHAQ', 'PRKAR2B', 'PRKACA', 'YWHAH', 'PRKCG', 'PRKCB', 'PDE4D', 'IGFBP2', 'PRKCD', 'YWHAZ', 'NFKB1', 'ACTA1', 'ADCY9', 'PRKAR1A', 'GNB1', 'CRH', 'CALM3', 'GNB5', 'ATF5', 'CALM2', 'ATF4']",0.7896799803991732,0,0,32
43,Supression of HMGB1 mediated inflammation by THBD WP4479,0.061292850464195754,3.6522540309312275,10.19742953472752,"['NFKBIA', 'HMGB1', 'IKBKG', 'NFKB1']",0.7896799803991732,0,0,4
44,Cell migration and invasion through p75NTR WP4561,0.06561662112293919,2.14935555770908,5.854686012080148,"['ARF1', 'TRIO', 'EFNB3', 'EFNA2', 'AKT3', 'RAC1', 'EFNA5', 'RHOA']",0.808774497039455,0,0,8
45,Glycolysis and Gluconeogenesis WP534,0.06635425760658406,1.8612821264536303,5.049188158673801,"['TPI1', 'GOT1', 'MPC1', 'MDH2', 'MPC2', 'PGK1', 'ALDOA', 'DLD', 'PFKM', 'GCK', 'PFKP']",0.808774497039455,0,0,11
46,Exercise-induced Circadian Regulation WP410,0.06715456112601974,1.7470879440885265,4.718462499729833,"['IDI1', 'DAZAP2', 'HSPA8', 'CBX3', 'AZIN1', 'DNAJA1', 'PPP2CB', 'SUMO1', 'STBD1', 'CRY2', 'TAB2', 'CLOCK', 'EIF4G2']",0.808774497039455,0,0,13
47,Peroxiredoxin 2 induced ovarian failure WP4873,0.07564056961383245,4.564473684210526,11.78438701126587,"['MAPK10', 'STAR', 'BAX']",0.8915930971502803,0,0,3
48,Neural Crest Cell Migration in Cancer WP4565,0.08401968302868941,1.8271018793273985,4.525190872445681,"['ARF1', 'TRIO', 'PIK3CA', 'SORT1', 'AKT3', 'PIK3R3', 'PIK3CD', 'RAC1', 'RHOA', 'NGEF']",0.8990448996341965,0,0,10
49,Fatty Acid Biosynthesis WP357,0.0848508918046819,2.1310496267018006,5.257000606879462,"['MECR', 'ECHS1', 'ACSS2', 'ECH1', 'ACACB', 'ACACA', 'DECR1']",0.8990448996341965,0,0,7
50,Unfolded protein response WP4925,0.0848508918046819,2.1310496267018006,5.257000606879462,"['XBP1', 'DDIT3', 'RTCB', 'EIF2AK3', 'CASP2', 'EIF2S1', 'ATF4']",0.8990448996341965,0,0,7
51,Gene regulatory network modelling somitogenesis  WP2854,0.08801965217975295,3.043325655369091,7.39587530601604,"['MESP2', 'HES7', 'EPHA4', 'RIPPLY2']",0.8990448996341965,0,0,4
52,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.08848363812050174,2.283009548896938,5.536155751197011,"['RAB5C', 'MRAS', 'RRAS', 'BRAF', 'HRAS', 'RAB5A']",0.8990448996341965,0,0,6
53,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.08848363812050174,2.283009548896938,5.536155751197011,"['MDH2', 'IDH2', 'IDH3B', 'SDHC', 'SDHD', 'DLD']",0.8990448996341965,0,0,6
54,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.09030162534113065,2.5363909004462,6.099005101072544,"['ITGB1', 'ZEB2', 'TERT', 'NRG3', 'ALPL']",0.8990448996341965,0,0,5
55,G Protein Signaling Pathways WP35,0.09035165592443442,1.4543499187774502,3.4963240091796863,"['PRKCG', 'PRKCB', 'PDE4D', 'PRKCD', 'AKAP5', 'ADCY1', 'ADCY7', 'AKAP3', 'RHOA', 'GNA13', 'GNG10', 'GNG3', 'ADCY9', 'RRAS', 'PRKAR1A', 'PRKAR2B', 'GNB1', 'GNB5', 'PRKACA', 'HRAS', 'CALM2']",0.8990448996341965,0,0,21
56,Common Pathways Underlying Drug Addiction WP2636,0.09087818480056861,1.7326676371576744,4.155344686776971,"['PRKCG', 'GRM5', 'RAP1A', 'PPP1R1A', 'PRKCB', 'CAMK2A', 'ADCY1', 'DRD1', 'PRKACA', 'CALM2', 'ACTG1']",0.8990448996341965,0,0,11
57,Prolactin Signaling Pathway WP2037,0.09418289120225193,1.4956093163035311,3.5334020402126356,"['ITGB1', 'GSK3B', 'IRS1', 'STAT1', 'PXN', 'AGAP2', 'YWHAZ', 'NFKB1', 'NFKBIA', 'ZAP70', 'PIK3CA', 'RPS6KA2', 'RAC1', 'JAK2', 'SOS1', 'PPIB', 'HRAS', 'NFKBIB']",0.9153916092289046,0,0,18
58,Lipid Metabolism Pathway WP3965,0.09705198020167652,1.9228301395994103,4.485017770891175,"['BCKDHA', 'ACSS2', 'PRKAR2B', 'PRKAR1A', 'AKT3', 'PRKAG1', 'PRKACA', 'ACACA']",0.9241854233074948,0,0,8
59,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.09842407937751298,1.7567019199066676,4.07286034142077,"['ITGB1', 'GSK3B', 'MAP1LC3A', 'EIF2B2', 'IRS1', 'PTEN', 'RICTOR', 'NFKB1', 'IGF1R', 'PDK1']",0.9241854233074948,0,0,10
60,miRNA regulation of prostate cancer signaling pathways WP3981,0.10661240796641057,1.787051102003382,4.000412852631745,"['PDGFRB', 'NFKBIA', 'GSK3B', 'PIK3CA', 'CREB3L1', 'AKT3', 'IKBKG', 'SOS1', 'NFKB1']",0.9310158482702636,0,0,9
61,Neural Crest Cell Migration during Development WP4564,0.10661240796641057,1.787051102003382,4.000412852631745,"['ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'PIK3R3', 'PIK3CD', 'RAC1', 'RHOA', 'NGEF']",0.9310158482702636,0,0,9
62,Androgen receptor signaling pathway WP138,0.10782200202093932,1.4281136288455176,3.180799699002163,"['NCOA1', 'GSK3B', 'NCOA2', 'PTEN', 'DSTN', 'PARK7', 'RNF4', 'NR2C2', 'RHOA', 'RHOB', 'CDC42', 'KAT2B', 'SUMO1', 'BAG1', 'RACK1', 'RAC1', 'CALR', 'FKBP4', 'PLPP1', 'RAN']",0.9310158482702636,0,0,20
63,DNA damage response (only ATM dependent) WP710,0.11097036155744819,1.3831866504008365,3.0409249601372874,"['WNT10B', 'GSK3B', 'WNT10A', 'IRS1', 'PTEN', 'PIK3R3', 'PIK3CD', 'HMGB1', 'NFKB1', 'RHOA', 'CDC42', 'MAPK10', 'CCND2', 'PIK3CA', 'AKT3', 'CAT', 'BAX', 'RAC1', 'SOS1', 'HRAS', 'SOS2', 'MAP3K4', 'PDK1']",0.9310158482702636,0,0,23
64,Dual hijack model of Vif in HIV infection WP3300,0.11510355882133448,3.4231085526315788,7.400497263232926,"['ELOB', 'ELOC', 'RBX1']",0.9310158482702636,0,0,3
65,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.11510355882133448,3.4231085526315788,7.400497263232926,"['HEY1', 'VEGFC', 'HIF1AN']",0.9310158482702636,0,0,3
66,Pentose Phosphate Metabolism WP134,0.11510355882133448,3.4231085526315788,7.400497263232926,"['G6PD', 'TALDO1', 'PGLS']",0.9310158482702636,0,0,3
67,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.11510355882133448,3.4231085526315788,7.400497263232926,"['NFKBIA', 'IKBKG', 'NFKB1']",0.9310158482702636,0,0,3
68,PDGFR-beta pathway WP3972,0.11546465326390587,1.8265568369028007,3.943154146700681,"['PDGFRB', 'MAP2K4', 'PIK3CA', 'STAT1', 'PRKCB', 'JAK2', 'SOS1', 'HRAS']",0.9310158482702636,0,0,8
69,Computational Model of Aerobic Glycolysis WP4629,0.11933985571365854,2.6083768156818503,5.54483507402415,"['TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.9310158482702636,0,0,4
70,Eukaryotic Transcription Initiation WP405,0.12021831667146135,1.6206485658353902,3.4332562829533413,"['TAF13', 'POLR3D', 'ERCC2', 'POLR2E', 'POLR1E', 'POLR2G', 'POLR2I', 'GTF2H3', 'POLR2J', 'POLR3K', 'POLR2K']",0.9310158482702636,0,0,11
71,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.12111794832720649,1.3002119960524874,2.7447350788317273,"['CYFIP1', 'GSK3B', 'RAB3A', 'IRS1', 'CAMK2A', 'ACACB', 'PTPRF', 'CDC42', 'GRIP1', 'RPS6KA5', 'RAP1A', 'DPYSL2', 'CFL1', 'RACK1', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'VAV3', 'CSNK2A1', 'STAT1', 'SORT1', 'PRKCD', 'EIF2S2', 'EIF2S1', 'NFKB1', 'NFKBIA', 'MAPK10', 'DLG1', 'ALPL', 'SQSTM1']",0.9310158482702636,0,0,31
72,Alpha 6 Beta 4 signaling pathway WP244,0.12435951763898828,1.7124670402109428,3.569772098215662,"['LAMA5', 'IRS1', 'PRKCD', 'GAB1', 'LAMC1', 'RAC1', 'SOS1', 'HRAS', 'RHOA']",0.9310158482702636,0,0,9
73,Amyotrophic lateral sclerosis (ALS) WP2447,0.12435951763898828,1.7124670402109428,3.569772098215662,"['CCS', 'TOMM40', 'ALS2', 'CAT', 'NEFL', 'BAX', 'RAC1', 'RAB5A', 'SOD1']",0.9310158482702636,0,0,9
74,Disruption of postsynaptic signaling by CNV WP4875,0.12435951763898828,1.7124670402109428,3.569772098215662,"['RPH3A', 'TJP1', 'RYR2', 'CYFIP1', 'DLG1', 'NLGN4X', 'NRXN1', 'CAMK2A', 'STX1A']",0.9310158482702636,0,0,9
75,Small cell lung cancer WP4658,0.1300689623238892,1.3708471211118465,2.7961038358556,"['ITGB1', 'LAMA5', 'GADD45A', 'PTEN', 'PIK3CD', 'PIK3R3', 'LAMC1', 'NFKB1', 'CKS1B', 'RXRB', 'NFKBIA', 'PIK3CA', 'AKT3', 'TRAF5', 'E2F1', 'CYCS', 'BAX', 'ITGAV', 'IKBKG', 'SKP1', 'NFKBIB']",0.9575071294274257,0,0,21
76,MET in type 1 papillary renal cell carcinoma WP4205,0.13208791137525944,1.4872050795795682,3.0105307756775592,"['RPL11', 'GAB1', 'PIK3CD', 'PIK3R3', 'BRAF', 'CDC42', 'RAP1A', 'PIK3CA', 'AKT3', 'RAC1', 'SOS1', 'JAK3', 'HRAS', 'SOS2']",0.9575071294274257,0,0,14
77,Retinoblastoma gene in cancer WP2446,0.1402978901620963,1.3778869572520367,2.706152526260929,"['PLK4', 'PRMT2', 'H2AFZ', 'SUV39H1', 'HMGB2', 'RPA2', 'HMGB1', 'ANLN', 'TFDP2', 'RBBP4', 'ORC1', 'STMN1', 'CHEK1', 'E2F1', 'CCDC6', 'CDK1', 'MCM4', 'SKP2', 'POLE']",0.9575071294274257,0,0,19
78,p38 MAPK Signaling Pathway WP400,0.1435773436530657,1.6438497033618984,3.1905173281483306,"['CDC42', 'MAP2K4', 'RPS6KA5', 'STAT1', 'DDIT3', 'RAC1', 'HRAS', 'MEF2D', 'HMGN1']",0.9575071294274257,0,0,9
79,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.14521252092878262,2.0749296786163147,4.003694978021497,"['RPH3A', 'SYTL1', 'GCC2', 'SYTL2', 'EXPH5']",0.9575071294274257,0,0,5
80,Overview of interferons-mediated signaling pathway WP4558,0.14521252092878262,2.0749296786163147,4.003694978021497,"['PIK3CA', 'STAT1', 'IFNE', 'JAK2', 'IFNAR1']",0.9575071294274257,0,0,5
81,AGE/RAGE pathway WP2324,0.1468274368053395,1.453299918965155,2.788151943079416,"['IRS1', 'PRKCB', 'STAT1', 'PRKCD', 'DDOST', 'RHOA', 'NFKB1', 'SOD1', 'CDC42', 'NFKBIA', 'ALPL', 'CYCS', 'RAC1', 'JAK2']",0.9575071294274257,0,0,14
82,PDGF Pathway WP2526,0.14962203668747148,1.5746330593358118,2.9912405431262776,"['CDC42', 'PDGFRB', 'NFKBIA', 'MAP2K4', 'STAT1', 'RAC1', 'SOS1', 'HRAS', 'NFKB1', 'RHOA']",0.9575071294274257,0,0,10
83,Hepatitis B infection WP4666,0.15036771775662713,1.2796417910447762,2.4245008740333605,"['YWHAB', 'PIK3R3', 'PIK3CD', 'YWHAQ', 'CREB3L4', 'CREB3L1', 'AKT3', 'IKBKG', 'JAK2', 'HRAS', 'JAK3', 'PRKCG', 'MAP2K4', 'PRKCB', 'STAT1', 'BRAF', 'YWHAZ', 'NFKB1', 'DDB1', 'MAPK10', 'PIK3CA', 'CYCS', 'BAX', 'TAB2', 'SOS1', 'SOS2', 'IFNAR1', 'ATF4']",0.9575071294274257,0,0,28
84,Cell cycle WP179,0.15221031068893862,1.2981768480028917,2.443807649742318,"['YWHAE', 'ANAPC13', 'GSK3B', 'YWHAB', 'ANAPC11', 'CCND2', 'ORC6', 'ORC1', 'YWHAQ', 'CDC27', 'CHEK1', 'E2F1', 'SKP2', 'BUB1', 'SKP1', 'YWHAH', 'CDKN2D', 'GADD45A', 'YWHAZ', 'RBX1', 'STAG1', 'STAG2', 'TFDP2', 'CDK1', 'MCM4']",0.9575071294274257,0,0,25
85,Cancer immunotherapy by CTLA4 blockade WP4582,0.15466607920681588,2.28216518591642,4.259631226113764,"['PIK3CA', 'PIK3CD', 'PIK3R3', 'HLA-DRB1']",0.9575071294274257,0,0,4
86,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.15466607920681588,2.28216518591642,4.259631226113764,"['NFKBIA', 'RRAS', 'IKBKG', 'NFKB1']",0.9575071294274257,0,0,4
87,Copper homeostasis WP3286,0.15774976374213578,1.4811274487948853,2.7352651180822454,"['BACE1', 'GSK3B', 'CCS', 'ATP7B', 'SCO1', 'PIK3CA', 'COX17', 'PTEN', 'ADAM10', 'COX11', 'ATOX1', 'SOD1']",0.9575071294274257,0,0,12
88,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.15774976374213578,1.4811274487948853,2.7352651180822454,"['NFKBIA', 'GSK3B', 'ZAP70', 'DLG1', 'PIK3CA', 'RRAS', 'CHP1', 'IKBKG', 'SOS1', 'CALM2', 'NFKB1', 'PDK1']",0.9575071294274257,0,0,12
89,Aspirin and miRNAs WP4707,0.16042244043501128,2.7382894736842105,5.010918283074923,"['ABCC4', 'NFKB1', 'PDK1']",0.9575071294274257,0,0,3
90,Canonical NF-KB pathway WP4562,0.16042244043501128,2.7382894736842105,5.010918283074923,"['NFKBIA', 'IKBKG', 'NFKB1']",0.9575071294274257,0,0,3
91,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.16042244043501128,2.7382894736842105,5.010918283074923,"['ELOB', 'ELOC', 'RBX1']",0.9575071294274257,0,0,3
92,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.16042244043501128,2.7382894736842105,5.010918283074923,"['UBE2V1', 'SQSTM1', 'NFKB1']",0.9575071294274257,0,0,3
93,Pregnane X receptor pathway WP2876,0.16179026177388248,1.8260125123477116,3.325998640074246,"['NCOA1', 'NCOA2', 'ABCC4', 'HSP90AA1', 'PSMC5', 'DNAJC7']",0.9575071294274257,0,0,6
94,Melanoma WP4685,0.1638696185845788,1.3981748577898796,2.5288567405313627,"['GADD45A', 'PTEN', 'PIK3CD', 'PIK3R3', 'BRAF', 'PIK3CA', 'AKT3', 'E2F1', 'BAX', 'CALM3', 'RAC1', 'SOS1', 'HRAS', 'SOS2', 'CALM2']",0.9575071294274257,0,0,15
95,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.16419346082239247,1.58051062319355,2.8555242013975013,"['STAR', 'CREB3L4', 'CREB3L1', 'CAMK2A', 'ITPR2', 'CALM3', 'REN', 'CALM2', 'ATF4']",0.9575071294274257,0,0,9
96,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.1796483975582428,1.370112285336856,2.352145315072938,"['HSPA9', 'HSPA8', 'PSMD13', 'SIAH2', 'UBE2J2', 'HSPA14', 'PSMD8', 'TUBB8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMD4', 'RNF19A', 'PSMC1']",0.9982792556030828,0,0,15
97,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.18993021268512744,1.4728311157908172,2.4465176690559343,"['ITGB1', 'MAPK10', 'ACTA1', 'YWHAQ', 'ITGB8', 'NF2', 'MAP4K5', 'TEAD1', 'MAP4K3', 'ACTG1']",0.9982792556030828,0,0,10
98,Estrogen signaling pathway WP712,0.19064252995837727,1.711763253210405,2.8369996867869323,"['PIK3CA', 'GNB1', 'BRAF', 'IKBKG', 'PRKACA', 'NFKB1']",0.9982792556030828,0,0,6
99,Glutathione metabolism WP100,0.19330279633598943,2.0284450294321963,3.3337441858134764,"['G6PD', 'GPX4', 'GPX3', 'GSS']",0.9982792556030828,0,0,4
100,Major receptors targeted by epinephrine and norepinephrine WP4589,0.19330279633598943,2.0284450294321963,3.3337441858134764,"['ADCY9', 'ADRA1D', 'ADCY1', 'ADCY7']",0.9982792556030828,0,0,4
101,Pancreatic adenocarcinoma pathway WP4263,0.19409037099812465,1.2952499407723288,2.123473421803053,"['STAT1', 'GADD45A', 'PRKCD', 'PEBP1', 'PIK3CD', 'PIK3R3', 'TGFA', 'BRAF', 'RHOA', 'NFKB1', 'CDC42', 'MAPK10', 'PIK3CA', 'AKT3', 'E2F1', 'BAX', 'RAC1', 'IKBKG', 'ARHGEF6']",0.9982792556030828,0,0,19
102,G1 to S cell cycle control WP45,0.19598666198647288,1.360241073874532,2.2167966756772057,"['CDKN2D', 'PRIM2', 'GADD45A', 'RPA2', 'CCND2', 'ORC6', 'TFDP2', 'ORC1', 'CREB3L4', 'CREB3L1', 'E2F1', 'CDK1', 'MCM4', 'POLE']",0.9982792556030828,0,0,14
103,IL17 signaling pathway WP2112,0.19951652847672852,1.5977108036890646,2.5752832546852678,"['GSK3B', 'PIK3CA', 'IKBKG', 'IL17RE', 'JAK2', 'NFKB1', 'NFKBIB']",0.9982792556030828,0,0,7
104,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.19951652847672852,1.5977108036890646,2.5752832546852678,"['MTMR2', 'RAB3A', 'RAB4B', 'HSPB8', 'MPZ', 'NEFL', 'NDRG1']",0.9982792556030828,0,0,7
105,Intraflagellar transport proteins binding to dynein WP4532,0.19951652847672852,1.5977108036890646,2.5752832546852678,"['IFT22', 'DYNC1LI2', 'IFT140', 'DYNLT3', 'IFT27', 'DYNLL1', 'DYNLL2']",0.9982792556030828,0,0,7
106,Nanoparticle-mediated activation of receptor signaling WP2643,0.19951652847672852,1.5977108036890646,2.5752832546852678,"['ITGB1', 'MAPK10', 'PXN', 'AKT3', 'PIK3CD', 'SOS1', 'HRAS']",0.9982792556030828,0,0,7
107,Resistin as a regulator of inflammation WP4481,0.19951652847672852,1.5977108036890646,2.5752832546852678,"['NFKBIA', 'PLCB4', 'PIK3CA', 'AKT3', 'PIK3CD', 'IKBKG', 'NFKB1']",0.9982792556030828,0,0,7
108,Fatty acid beta-oxidation WP143,0.20537646431181583,1.5216913783635366,2.4087013712106047,"['ECHS1', 'ACSS2', 'TPI1', 'CPT2', 'LPL', 'CPT1B', 'DLD', 'DECR1']",0.9982792556030828,0,0,8
109,ErbB signaling pathway WP673,0.20893670861421507,1.2761097494553377,1.9980355369055518,"['PRKCG', 'GSK3B', 'MAP2K4', 'PRKCB', 'CAMK2A', 'GAB1', 'PIK3CD', 'PIK3R3', 'TGFA', 'NRG1', 'BRAF', 'MAPK10', 'NRG3', 'PIK3CA', 'AKT3', 'ABL2', 'SOS1', 'HRAS', 'SOS2']",0.9982792556030828,0,0,19
110,Senescence and Autophagy in Cancer WP615,0.20893670861421507,1.2761097494553377,1.9980355369055518,"['GABARAPL2', 'UVRAG', 'GSK3B', 'BECN1', 'GABARAPL1', 'PTEN', 'BRAF', 'GABARAP', 'IGF1R', 'MAP1LC3B', 'ING2', 'MAP1LC3A', 'E2F1', 'COL10A1', 'SLC39A1', 'SQSTM1', 'HRAS', 'SLC39A4', 'SLC39A3']",0.9982792556030828,0,0,19
111,PTF1A related regulatory pathway WP4147,0.2099872448171998,2.2817434210526315,3.561136327128032,"['KAT2B', 'PROX1', 'FGF10']",0.9982792556030828,0,0,3
112,Serotonin Transporter Activity WP1455,0.2099872448171998,2.2817434210526315,3.561136327128032,"['PPP2CB', 'IL1R1', 'STX1A']",0.9982792556030828,0,0,3
113,Apoptosis Modulation by HSP70 WP384,0.21093759269334011,1.7554565250417784,2.7318290831882956,"['MAPK10', 'CASP6', 'CASP2', 'CYCS', 'NFKB1']",0.9982792556030828,0,0,5
114,Insulin Signaling WP481,0.22023211133632004,1.1885741441273596,1.7983997279982271,"['GSK3B', 'ARF1', 'IRS1', 'STXBP4', 'STXBP1', 'PTEN', 'PIK3R3', 'PIK3CD', 'PTPRF', 'IGF1R', 'GYS2', 'RPS6KA5', 'RPS6KA2', 'RAC1', 'MAP4K5', 'HRAS', 'MAP3K4', 'MAP4K3', 'CAP1', 'MAP2K4', 'XBP1', 'PRKCB', 'PRKCD', 'GAB1', 'MAPK10', 'EHD2', 'TBC1D4', 'PIK3CA', 'SOS1', 'SOS2', 'PFKM', 'VAMP2']",0.9982792556030828,0,0,32
115,EPO Receptor Signaling WP581,0.2212709296254917,1.61095508338337,2.4299121344911727,"['PTPRU', 'IRS1', 'STAT1', 'JAK2', 'SOS1', 'PDK1']",0.9982792556030828,0,0,6
116,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension) WP4661,0.22198644835331158,3.0419818042310642,4.578605275701416,"['UROC1', 'FTCD']",0.9982792556030828,0,0,2
117,Composition of Lipid Particles WP3601,0.22198644835331158,3.0419818042310642,4.578605275701416,"['APOA1', 'LPL']",0.9982792556030828,0,0,2
118,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.22198644835331158,3.0419818042310642,4.578605275701416,"['MAS1', 'REN']",0.9982792556030828,0,0,2
119,Integrin-mediated Cell Adhesion WP185,0.22236086022643378,1.2512291609079251,1.8811651368947775,"['VASP', 'ITGB1', 'VAV3', 'PXN', 'BRAF', 'ITGAE', 'CDC42', 'MAPK10', 'RAP1A', 'CAPNS1', 'CAPN7', 'ITGA10', 'AKT3', 'ITGA8', 'RHO', 'ITGB8', 'ITGAV', 'RAC1', 'SOS1', 'HRAS']",0.9982792556030828,0,0,20
120,Leptin signaling pathway WP2034,0.2296127692974038,1.2817507925744325,1.8859181287800784,"['NCOA1', 'GSK3B', 'IRS1', 'STAT1', 'PTEN', 'ACACB', 'RHOA', 'ACACA', 'NFKB1', 'CDC42', 'BAX', 'RAC1', 'IKBKG', 'JAK2', 'SOS1', 'HRAS']",0.9982792556030828,0,0,16
121,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.22963496414899143,1.1369733924611973,1.6727884115540852,"['ITGB1', 'GSK3B', 'HSP90AB1', 'IRS1', 'PTEN', 'PIK3CD', 'ITGAE', 'LAMC1', 'IGF1R', 'GYS2', 'CREB3L4', 'CREB3L1', 'AKT3', 'ITGB8', 'ITGAV', 'IKBKG', 'JAK2', 'HRAS', 'JAK3', 'RAB8A', 'PDGFRB', 'RAB2A', 'HSP90AA1', 'PPP2R5A', 'TBC1D1', 'PIK3CA', 'CDC37', 'ITGA8', 'EIF4E2', 'SOS1', 'ATF4', 'IFNAR1', 'LAMA5', 'LPAR2', 'EFNA5', 'ACACA', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'FGF22', 'EIF4B', 'VEGFC', 'EFNA2', 'FGF14', 'COL5A1', 'RAB14', 'ITGA10', 'GNB1', 'FGF12', 'FGF10']",0.9982792556030828,0,0,51
122,Calcium Regulation in the Cardiac Cell WP536,0.23069753799987391,1.1953193533888191,1.7531124828857125,"['YWHAE', 'RYR2', 'YWHAB', 'CAMK2A', 'ITPR2', 'ADRA1D', 'ADCY1', 'ADCY7', 'SLC8A1', 'RGS4', 'GNG3', 'YWHAQ', 'PRKAR2B', 'ANXA6', 'PRKACA', 'YWHAH', 'PRKCG', 'PRKCB', 'PRKCD', 'ATP2B3', 'YWHAZ', 'ADCY9', 'PRKAR1A', 'GNB1', 'CALM3', 'CALR', 'GNB5', 'CALM2']",0.9982792556030828,0,0,28
123,Melatonin metabolism and effects WP3298,0.23130188784529965,1.4607182866556836,2.138537654240002,"['GSK3B', 'AANAT', 'PER3', 'CAMK2A', 'CRY2', 'CLOCK', 'CALM2', 'NFKB1']",0.9982792556030828,0,0,8
124,PPAR signaling pathway WP3942,0.23434324793423658,1.3362409572627565,1.9388433595653922,"['RXRB', 'FABP3', 'CPT2', 'FABP5', 'FABP6', 'FABP7', 'OLR1', 'APOA1', 'LPL', 'PPARG', 'CPT1B', 'SLC27A5']",0.9982792556030828,0,0,12
125,Fatty acid transporters WP5061,0.234503267467416,1.8254689042448173,2.6474515524574405,"['FABP3', 'FABP5', 'FABP6', 'FABP7']",0.9982792556030828,0,0,4
126,FOXA2 pathway WP5066,0.234503267467416,1.8254689042448173,2.6474515524574405,"['ABCC4', 'IRS1', 'ACACA', 'SLC27A5']",0.9982792556030828,0,0,4
127,Cytosolic DNA-sensing pathway WP4655,0.23468908832679916,1.3572523711046138,1.967328719435528,"['NFKBIA', 'POLR3GL', 'POLR3D', 'POLR2E', 'ISG15', 'IKBKG', 'POLR3K', 'POLR2K', 'NFKB1', 'POLR2L', 'NFKBIB']",0.9982792556030828,0,0,11
128,Rett syndrome causing genes WP4312,0.23468908832679916,1.3572523711046138,1.967328719435528,"['EIF2B2', 'TRRAP', 'SATB2', 'STXBP1', 'SCN8A', 'GABRA3', 'BRAF', 'TCF4', 'SMARCA1', 'RHOBTB2', 'SCN1A']",0.9982792556030828,0,0,11
129,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.24681132730304603,1.629949214708925,2.2805126235626028,"['PRKAG1', 'PDHB', 'ACACB', 'ACACA', 'PDK1']",0.9982792556030828,0,0,5
130,Nucleotide metabolism WP404,0.24681132730304603,1.629949214708925,2.2805126235626028,"['PRPS2', 'POLD1', 'NME2', 'OAZ1', 'SRM']",0.9982792556030828,0,0,5
131,RAS and bradykinin pathways in COVID-19 WP4969,0.24681132730304603,1.629949214708925,2.2805126235626028,"['CYP24A1', 'REN', 'KLKB1', 'NFKB1', 'RHOA']",0.9982792556030828,0,0,5
132,Gastrin signaling pathway WP4659,0.24753821998974593,1.2104505409921713,1.6900192854365776,"['ITGB1', 'GSK3B', 'IRS1', 'PRKCD', 'PXN', 'PIK3R3', 'NFKB1', 'RHOA', 'RHOB', 'NFKBIA', 'CDC42', 'TJP1', 'CCKBR', 'PIK3CA', 'TCF4', 'PPARG', 'RAC1', 'PRKACA', 'JAK2', 'SOS1', 'HRAS', 'MEF2D']",0.9982792556030828,0,0,22
133,Apoptosis WP254,0.2495412370902749,1.2682555408777338,1.7605049571736964,"['HRK', 'HELLS', 'MAP2K4', 'CRADD', 'NFKB1', 'IGF1R', 'NFKBIA', 'MAPK10', 'CASP6', 'CASP2', 'CYCS', 'BAX', 'IKBKG', 'BCL2L2', 'NFKBIB']",0.9982792556030828,0,0,15
134,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.25168698315642085,1.2783492901947837,1.7635711719434144,"['STAT1', 'PDE4D', 'BRAF', 'TTF1', 'IGF1R', 'MYL12B', 'GNA13', 'RAP1A', 'PIK3CA', 'APEX1', 'GNB1', 'E2F1', 'JAK2', 'HRAS']",0.9982792556030828,0,0,14
135,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.25678407487143623,1.4522547610492273,1.9743689902198673,"['GSK3B', 'PIK3CA', 'PTEN', 'PIK3R3', 'RICTOR', 'HRAS', 'PDK1']",0.9982792556030828,0,0,7
136,ATM Signaling Network in Development and Disease  WP3878,0.25805587811992187,1.3425845115494268,1.8186369671928044,"['MDC1', 'G6PD', 'CHEK1', 'RNF8', 'CDK1', 'IKBKG', 'PPM1D', 'BUB1', 'NFKB1', 'HMGN1']",0.9982792556030828,0,0,10
137,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.25805587811992187,1.3425845115494268,1.8186369671928044,"['ADCY9', 'TMEM43', 'CFL1', 'BANF1', 'ADCY1', 'SOS1', 'ADCY7', 'HRAS', 'SOS2', 'RHOA']",0.9982792556030828,0,0,10
138,Signaling of Hepatocyte Growth Factor Receptor WP313,0.2582940543606299,1.4044354327715118,1.901123289324915,"['ITGB1', 'RAP1A', 'PIK3CA', 'PXN', 'PTEN', 'GAB1', 'SOS1', 'HRAS']",0.9982792556030828,0,0,8
139,ACE Inhibitor Pathway WP554,0.2622590709446494,1.955639097744361,2.6174712595772904,"['MAS1', 'REN', 'NR3C2']",0.9982792556030828,0,0,3
140,Cytokines and Inflammatory Response WP530,0.2622590709446494,1.955639097744361,2.6174712595772904,"['IL11', 'IL15', 'HLA-DRB1']",0.9982792556030828,0,0,3
141,Dopamine metabolism WP2436,0.2622590709446494,1.955639097744361,2.6174712595772904,"['PPP2CB', 'PRKACA', 'SOD1']",0.9982792556030828,0,0,3
142,TCA cycle in senescence WP5050,0.2622590709446494,1.955639097744361,2.6174712595772904,"['GOT1', 'BRAF', 'PDK1']",0.9982792556030828,0,0,3
143,Corticotropin-releasing hormone signaling pathway WP2355,0.2624452286211374,1.23203138933476,1.6481042477201528,"['GSK3B', 'NCOA2', 'HSP90AA1', 'PARP1', 'PRKCB', 'PRKCD', 'CAMK2A', 'BRAF', 'RHOA', 'ACACA', 'NFKB1', 'NFKBIA', 'STAR', 'GNB1', 'CRH', 'TCF4', 'GNB5']",0.9982792556030828,0,0,17
144,Selenium Micronutrient Network WP15,0.26848009973667547,1.2451062807733877,1.6372879697803804,"['GPX4', 'GPX3', 'APOA1', 'TXN', 'NFKB1', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX5', 'PRDX4', 'FLAD1', 'CAT', 'SELENOW', 'SEPHS2', 'MSRB1']",0.9982792556030828,0,0,15
145,PI3K-Akt signaling pathway WP4172,0.27054030710953386,1.1107867202601944,1.4521694484737315,"['ITGB1', 'GSK3B', 'HSP90AB1', 'IRS1', 'PTEN', 'PIK3CD', 'LAMC1', 'IGF1R', 'GYS2', 'CCND2', 'CREB3L4', 'CREB3L1', 'AKT3', 'ITGB8', 'ITGAV', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'JAK3', 'PDGFRB', 'HSP90AA1', 'PPP2R5A', 'PIK3CA', 'CDC37', 'ITGA8', 'EIF4E2', 'SOS1', 'SOS2', 'ATF4', 'IFNAR1', 'LAMA5', 'TGFA', 'PIK3R3', 'LPAR2', 'EFNA5', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'FGF22', 'EIF4B', 'VEGFC', 'NFKB1', 'EFNA2', 'FGF14', 'ITGA10', 'GNB1', 'COL9A3', 'PKN2', 'GNB5', 'FGF12', 'FGF10']",0.9982792556030828,0,0,53
146,Cholesterol Biosynthesis Pathway WP197,0.2775153522983692,1.6593975290915073,2.127146884568833,"['IDI1', 'NSDHL', 'PMVK', 'LSS']",0.9982792556030828,0,0,4
147,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.2775153522983692,1.6593975290915073,2.127146884568833,"['CD63', 'CD81', 'PTEN', 'SOD1']",0.9982792556030828,0,0,4
148,Globo Sphingolipid Metabolism WP1424,0.28408438823296045,1.521176212420452,1.9143758382510376,"['B3GALNT1', 'ST6GAL2', 'ST8SIA1', 'B3GALT5', 'ST6GALNAC3']",0.9982792556030828,0,0,5
149,"Relationship between inflammation, COX-2 and EGFR WP4483",0.28408438823296045,1.521176212420452,1.9143758382510376,"['PIK3CA', 'AKT3', 'PIK3CD', 'BRAF', 'HRAS']",0.9982792556030828,0,0,5
150,EGF/EGFR signaling pathway WP437,0.28531187686961595,1.141683266932271,1.4318676340492646,"['NDUFA13', 'STXBP1', 'CAMK2A', 'PTEN', 'PEBP1', 'NEDD8', 'CDC42', 'RPS6KA5', 'RAP1A', 'RPS6KA2', 'CFL1', 'STMN1', 'E2F1', 'AP2S1', 'RICTOR', 'RAC1', 'JAK2', 'HRAS', 'MEF2D', 'MAP3K4', 'AP2M1', 'VAV3', 'PRKCB', 'STAT1', 'PRKCD', 'GAB1', 'BRAF', 'SOS1', 'RAB5A', 'SOS2', 'PTPN5']",0.9982792556030828,0,0,31
151,Cannabinoid receptor signaling WP3869,0.2866368603652095,1.4411729026220474,1.800801977117621,"['MAPK10', 'PRKAR2B', 'PRKAR1A', 'ADCY1', 'PRKACA', 'ADCY7']",0.9982792556030828,0,0,6
152,Glycosylation and related congenital defects WP4521,0.2866368603652095,1.4411729026220474,1.800801977117621,"['DPM2', 'DPM3', 'MPI', 'SRD5A3', 'ALG14', 'ALG3']",0.9982792556030828,0,0,6
153,Striated Muscle Contraction Pathway WP383,0.2866368603652095,1.4411729026220474,1.800801977117621,"['MYOM1', 'ACTA1', 'TPM3', 'TNNC2', 'TPM1', 'ACTG1']",0.9982792556030828,0,0,6
154,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.28703664455295014,1.389013003379733,1.7336901768239186,"['RAP1A', 'YWHAQ', 'LPL', 'RAC1', 'NDRG1', 'TEAD1', 'RHOA']",0.9982792556030828,0,0,7
155,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.2951593838514428,2.281321933574482,2.783759784146339,"['GGCT', 'GSS']",0.9982792556030828,0,0,2
156,Pilocytic astrocytoma WP2253,0.2951593838514428,2.281321933574482,2.783759784146339,"['BRAF', 'SOS1']",0.9982792556030828,0,0,2
157,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.2951593838514428,2.281321933574482,2.783759784146339,"['PTEN', 'IGF1R']",0.9982792556030828,0,0,2
158,Focal Adhesion WP306,0.30271645476234077,1.118370061692785,1.3364060400315372,"['ITGB1', 'GSK3B', 'LAMA5', 'PXN', 'PTEN', 'TESK2', 'PIK3R3', 'PIK3CD', 'LAMC1', 'MYL12B', 'ACTG1', 'IGF1R', 'CDC42', 'CCND2', 'RAP1A', 'AKT3', 'ITGB8', 'ITGAV', 'RAC1', 'HRAS', 'PRKCG', 'VASP', 'VAV3', 'PDGFRB', 'PRKCB', 'VEGFC', 'BRAF', 'PARVB', 'RHOA', 'MAPK10', 'MYL7', 'PIK3CA', 'ITGA10', 'ITGA8', 'SOS1', 'PPP1R12C']",0.9982792556030828,0,0,36
159,Alzheimer's disease WP2059,0.30316883042451515,1.1973549529643048,1.4290017468295355,"['PSENEN', 'ATP5MD', 'GSK3B', 'PSEN2', 'EIF2AK3', 'ADAM10', 'ITPR2', 'LPL', 'IDE', 'BACE1', 'NCSTN', 'PLCB4', 'CHP1', 'CYCS', 'CALM3', 'CALM2']",0.9982792556030828,0,0,16
160,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.303451897442301,1.255186345646438,1.4968501013235491,"['NFKBIA', 'MAPK10', 'OTUD5', 'TKFC', 'IFNE', 'DHX58', 'PIN1', 'ISG15', 'IKBKG', 'NFKB1', 'NFKBIB']",0.9982792556030828,0,0,11
161,IL-6 signaling pathway WP364,0.31114058288476654,1.2836086849044166,1.4986265327228008,"['NCOA1', 'GSK3B', 'MAP2K4', 'STAT1', 'PRKCD', 'GAB1', 'RAC1', 'JAK2', 'SOS1']",0.9982792556030828,0,0,9
162,Metabolic reprogramming in colon cancer WP4290,0.31114058288476654,1.2836086849044166,1.4986265327228008,"['G6PD', 'MDH2', 'IDH2', 'PGK1', 'PYCR1', 'TALDO1', 'PYCR2', 'PDHB', 'GLS']",0.9982792556030828,0,0,9
163,"NAD metabolism, sirtuins and aging WP3630",0.31585376990132097,1.7110608552631579,1.9719564435698225,"['PARP1', 'PPARG', 'NFKB1']",0.9982792556030828,0,0,3
164,Purine metabolism WP4792,0.31585376990132097,1.7110608552631579,1.9719564435698225,"['DGUOK', 'ITPA', 'APRT']",0.9982792556030828,0,0,3
165,Transcription co-factors SKI and SKIL protein partners WP4533,0.32161628959970956,1.521004716463749,1.7254218050831918,"['PRMT5', 'ING2', 'SATB2', 'TEAD1']",0.9982792556030828,0,0,4
166,3q29 copy number variation syndrome WP4906,0.32230946164888,1.2171120642252282,1.3780667779543454,"['DLG1', 'NCBP2', 'DYNLT3', 'CEP350', 'PXN', 'RNF8', 'ADAM10', 'PIK3R3', 'WDR53', 'NF2', 'DYNLL1', 'DYNLL2']",0.9982792556030828,0,0,12
167,Notch Signaling Pathway Netpath WP61,0.32230946164888,1.2171120642252282,1.3780667779543454,"['PSENEN', 'GSK3B', 'NUMBL', 'NCSTN', 'MAML2', 'HEY1', 'NOTCH4', 'PSEN2', 'JAK2', 'NFKB1', 'SKP1', 'DLL3']",0.9982792556030828,0,0,12
168,Vitamin D-sensitive calcium signaling in depression WP4698,0.34387437562179657,1.2588763278986537,1.3438238868380745,"['KDM6B', 'GRM5', 'G6PD', 'CALB1', 'GPX4', 'ITPR2', 'ATP2B3', 'SLC8A1']",0.9982792556030828,0,0,8
169,IL-1 signaling pathway WP195,0.35185720932948417,1.1952428068852872,1.2484667790303465,"['NFKBIA', 'MAP2K4', 'IL1R1', 'PELI2', 'TAB2', 'IKBKG', 'UBE2V1', 'ECSIT', 'SQSTM1', 'NFKB1', 'NFKBIB']",0.9982792556030828,0,0,11
170,Oxidative Stress WP408,0.3553783822492523,1.3037301848628815,1.3488029946701774,"['MAPK10', 'GPX3', 'CAT', 'NFKB1', 'TXN2', 'SOD1']",0.9982792556030828,0,0,6
171,Phosphoinositides metabolism WP4971,0.35859821364029437,1.2009127665851076,1.23159932940268,"['MTMR10', 'MTMR2', 'PLCB4', 'MTMR3', 'PIK3CA', 'PTEN', 'MTMR8', 'PIK3CD', 'PIP5K1B', 'MTM1']",0.9982792556030828,0,0,10
172,Synaptic Vesicle Pathway WP2267,0.35859821364029437,1.2009127665851076,1.23159932940268,"['NAPA', 'RAB3A', 'STXBP1', 'AP2S1', 'CLTA', 'PARK7', 'SYP', 'AP2M1', 'VAMP2', 'STX1A']",0.9982792556030828,0,0,10
173,NRF2-ARE regulation WP4357,0.36102445514703435,1.3420206792394378,1.3672635247740872,"['GSK3B', 'AIMP2', 'MAF', 'PIK3CA', 'RBX1']",0.9982792556030828,0,0,5
174,"Cerebral organic acidurias, including diseases WP4519",0.36718169669578243,1.8249260111805328,1.8283905731322818,"['MDH2', 'IDH2']",0.9982792556030828,0,0,2
175,Insulin signaling in adipocytes (diabetic condition) WP3635,0.36718169669578243,1.8249260111805328,1.8283905731322818,"['TBC1D4', 'IRS1']",0.9982792556030828,0,0,2
176,Insulin signaling in adipocytes (normal condition) WP3634,0.36718169669578243,1.8249260111805328,1.8283905731322818,"['TBC1D4', 'IRS1']",0.9982792556030828,0,0,2
177,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.36889140782970237,1.1651515896024764,1.1619508785440298,"['PRKCG', 'RXRB', 'PLCB4', 'CYP24A1', 'PRKCB', 'STAT1', 'PRKCD', 'CAMK2A', 'SP3', 'ISG15', 'HRAS', 'NFKB1']",0.9982792556030828,0,0,12
178,Oncostatin M Signaling Pathway WP2374,0.36889140782970237,1.1651515896024764,1.1619508785440298,"['NFKBIA', 'IRS1', 'PRKCB', 'STAT1', 'PRKCD', 'PXN', 'RICTOR', 'JAK2', 'SOS1', 'JAK3', 'HRAS', 'NFKB1']",0.9982792556030828,0,0,12
179,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3695829870853418,1.5208333333333333,1.5138070390577714,"['LPL', 'APOA1', 'LDLRAP1']",0.9982792556030828,0,0,3
180,NO metabolism in cystic fibrosis WP4947,0.3695829870853418,1.5208333333333333,1.5138070390577714,"['PRMT6', 'PRMT5', 'PRMT2']",0.9982792556030828,0,0,3
181,Osteoclast Signaling WP12,0.3695829870853418,1.5208333333333333,1.5138070390577714,"['AIMP2', 'ATP6V1G1', 'IFNAR1']",0.9982792556030828,0,0,3
182,RalA downstream regulated genes WP2290,0.3695829870853418,1.5208333333333333,1.5138070390577714,"['CDC42', 'RAC1', 'HRAS']",0.9982792556030828,0,0,3
183,ATM Signaling Pathway WP2516,0.373323787777193,1.2168259198242724,1.1989497397028992,"['NFKBIA', 'MDC1', 'CRADD', 'GADD45A', 'CHEK1', 'CDK1', 'CASP2', 'IKBKG']",0.9982792556030828,0,0,8
184,Pathways Regulating Hippo Signaling WP4540,0.3751008479754031,1.1244097052597297,1.1025515867621944,"['PDGFRB', 'PRKCG', 'PRKCB', 'PRKCD', 'PRKAG1', 'CDH8', 'RHOA', 'IGF1R', 'CDC42', 'PLCB4', 'PRKAR1A', 'PRKAR2B', 'NF2', 'RAC1', 'PRKACA', 'TEAD1', 'CDH18']",0.9982792556030828,0,0,17
185,CAMKK2  Pathway WP4874,0.38145700969233887,1.2284762339110165,1.1839527198563997,"['FIS1', 'MAP1LC3A', 'MAF', 'RAC1', 'SQSTM1', 'CALM2', 'CAMKK2']",0.9982792556030828,0,0,7
186,MAPK Cascade WP422,0.38145700969233887,1.2284762339110165,1.1839527198563997,"['MAPK10', 'MAP2K4', 'RRAS', 'BRAF', 'SOS1', 'HRAS', 'SOS2']",0.9982792556030828,0,0,7
187,Nuclear receptors WP170,0.38145700969233887,1.2284762339110165,1.1839527198563997,"['RXRB', 'THRA', 'RORA', 'ROR1', 'PPARG', 'NR2C2', 'NR3C1']",0.9982792556030828,0,0,7
188,Glioblastoma signaling pathways WP2261,0.3824155681239615,1.1233462936138854,1.0798136894463533,"['PRKCG', 'PDGFRB', 'MAP2K4', 'IRS1', 'PRKCB', 'PRKCD', 'PTEN', 'GAB1', 'PIK3CD', 'BRAF', 'IGF1R', 'CCND2', 'PIK3CA', 'AKT3', 'E2F1', 'HRAS']",0.9982792556030828,0,0,16
189,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.384272898577978,1.1408415841584159,1.0911035212115434,"['IDI1', 'SEC24B', 'SAR1A', 'PRKAG1', 'LPL', 'LSS', 'ACACA', 'CDK8', 'RBP4', 'PIK3CA', 'PPARG', 'PRKACA', 'SEC24D']",0.9982792556030828,0,0,13
190,Aryl Hydrocarbon Receptor Pathway WP2873,0.3902450712825017,1.2443799203759691,1.1709370521467446,"['NCOA1', 'HSP90AA1', 'PTGES3', 'CDC37', 'BAX', 'CAP2']",0.9982792556030828,0,0,6
191,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.3902450712825017,1.2443799203759691,1.1709370521467446,"['ITGB1', 'LAMA5', 'EDA', 'CCND2', 'NFKB1', 'GTPBP4']",0.9982792556030828,0,0,6
192,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.3902450712825017,1.2443799203759691,1.1709370521467446,"['ADAMTS2', 'CRTAP', 'CREB3L1', 'PLOD2', 'P4HB', 'PPIB']",0.9982792556030828,0,0,6
193,Hippo-Merlin Signaling Dysregulation WP4541,0.3909051240530009,1.099681557855637,1.0329203280654156,"['PDGFRB', 'ITGB1', 'ITGAE', 'CDH8', 'IGF1R', 'RBX1', 'DCAF1', 'DDB1', 'PLCB4', 'PRKAR1A', 'PRKAR2B', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGAV', 'NF2', 'PRKACA', 'HRAS', 'TEAD1', 'CDH18']",0.9982792556030828,0,0,20
194,Toll-like Receptor Signaling Pathway WP75,0.4201471553848875,1.101387734656937,0.9550686594838538,"['MAP2K4', 'STAT1', 'PIK3R3', 'PIK3CD', 'NFKB1', 'NFKBIA', 'MAPK10', 'PIK3CA', 'AKT3', 'TAB2', 'RAC1', 'IKBKG', 'IFNAR1', 'NFKBIB']",0.9982792556030828,0,0,14
195,Development and heterogeneity of the ILC family WP3893,0.42246702596867514,1.3686513157894737,1.1792900304805145,"['IL15', 'ZBTB16', 'RORA']",0.9982792556030828,0,0,3
196,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.42246702596867514,1.3686513157894737,1.1792900304805145,"['CDK8', 'H2AFY', 'E2F1']",0.9982792556030828,0,0,3
197,Homologous recombination WP186,0.42246702596867514,1.3686513157894737,1.1792900304805145,"['POLD4', 'POLD1', 'POLD2']",0.9982792556030828,0,0,3
198,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.42246702596867514,1.3686513157894737,1.1792900304805145,"['STAG1', 'BUB1', 'ANAPC11']",0.9982792556030828,0,0,3
199,Aryl Hydrocarbon Receptor Netpath WP2586,0.4325341406122183,1.1406095551894564,0.9559380449569183,"['RET', 'HSP90AA1', 'KLF6', 'CDC37', 'E2F1', 'LPL', 'HRAS', 'NFKB1']",0.9982792556030828,0,0,8
200,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.4361014222309823,1.5206620629178997,1.2619677062589003,"['HSD11B2', 'STAR']",0.9982792556030828,0,0,2
201,HIF1A and PPARG regulation of glycolysis WP2456,0.4361014222309823,1.5206620629178997,1.2619677062589003,"['TPI1', 'PPARG']",0.9982792556030828,0,0,2
202,Vitamin D Metabolism WP1531,0.4361014222309823,1.5206620629178997,1.2619677062589003,"['RXRB', 'CYP24A1']",0.9982792556030828,0,0,2
203,Interferon type I signaling pathways WP585,0.43703837874563745,1.1127998520341287,0.9211025670883538,"['ZAP70', 'RPS6KA5', 'RAP1A', 'IRS1', 'STAT1', 'RACK1', 'PIK3CD', 'RAC1', 'EIF4B', 'IFNAR1']",0.9982792556030828,0,0,10
204,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.43838985772276945,1.2005821004123212,0.9900560412183804,"['RBBP4', 'H3F3B', 'CBX3', 'SUV39H1', 'E2F1']",0.9982792556030828,0,0,5
205,miRNAs involvement in the immune response in sepsis WP4329,0.43838985772276945,1.2005821004123212,0.9900560412183804,"['NFKBIA', 'TAB2', 'IKBKG', 'ELANE', 'NFKB1']",0.9982792556030828,0,0,5
206,Endometrial cancer WP4155,0.4399917743648333,1.0950049488617617,0.8989982383343809,"['GSK3B', 'PIK3CA', 'GADD45A', 'AKT3', 'PTEN', 'PIK3CD', 'PIK3R3', 'BAX', 'BRAF', 'SOS1', 'HRAS', 'SOS2']",0.9982792556030828,0,0,12
207,Fragile X Syndrome  WP4549,0.4457667760714587,1.0566316486349936,0.8537154594761346,"['CYFIP1', 'EPHA4', 'KCND2', 'CAMK2A', 'AGAP2', 'PTEN', 'GAB1', 'CLTA', 'BRAF', 'AKAP5', 'GRIP2', 'EEF1A1', 'GRIP1', 'GRM5', 'ALDH5A1', 'PRKAR1A', 'AP2S1', 'PRKACA', 'SOS1', 'PTPN5', 'AP2M1', 'PDK1']",0.9982792556030828,0,0,22
208,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.44613157119237634,1.052946722042449,0.8498768574428313,"['RET', 'YWHAE', 'RYR2', 'YWHAB', 'CDCA7L', 'MBD1', 'RORA', 'SSTR1', 'NR3C1', 'ASCL1', 'YWHAZ', 'NFKB1', 'GCK', 'HSP90B1', 'YWHAQ', 'PRKAR1A', 'PRKAR2B', 'SP3', 'SCN5A', 'PRKACA', 'SCN3B', 'ALDOA', 'VAMP2', 'YWHAH']",0.9982792556030828,0,0,24
209,GABA metabolism (aka GHB) WP4157,0.44830002862593904,2.2809007232084153,1.829949689375512,['AKR7A2'],0.9982792556030828,0,0,1
210,B Cell Receptor Signaling Pathway WP23,0.4538935685574765,1.0624903801754657,0.8392532239685546,"['GSK3B', 'CD81', 'PRKCB', 'PRKCD', 'CAMK2A', 'GAB1', 'BRAF', 'ILF2', 'NFKB1', 'NFKBIA', 'CDC42', 'PIP5K1B', 'RAC1', 'IKBKG', 'SOS1', 'HRAS', 'MEF2D']",0.9982792556030828,0,0,17
211,Ebstein-Barr virus LMP1 signaling WP262,0.45412522253599197,1.2165405286826807,0.9603155586385396,"['NFKBIA', 'HSP90AA1', 'IKBKG', 'NFKB1']",0.9982792556030828,0,0,4
212,Imatinib and Chronic Myeloid Leukemia WP3640,0.45412522253599197,1.2165405286826807,0.9603155586385396,"['PDGFRB', 'GADD45A', 'PIM2', 'SKP2']",0.9982792556030828,0,0,4
213,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.45412522253599197,1.2165405286826807,0.9603155586385396,"['RPS6KA5', 'RAP1A', 'BRAF', 'NR3C1']",0.9982792556030828,0,0,4
214,Thermogenesis WP4321,0.45421590862012967,1.0571646341463414,0.8342959603353961,"['SMARCD1', 'SMARCD3', 'PRKAG1', 'ADCY1', 'CPT1B', 'ARID1B', 'ADCY7', 'ACTG1', 'ADCY9', 'CPT2', 'CREB3L4', 'RPS6KA2', 'CREB3L1', 'PPARG', 'PRKACA', 'SOS1', 'HRAS', 'SOS2', 'MGLL']",0.9982792556030828,0,0,19
215,Breast cancer pathway WP4262,0.4543537520304461,1.0464734528608168,0.8255411349320128,"['GSK3B', 'NOTCH4', 'PTEN', 'PIK3R3', 'PIK3CD', 'IGF1R', 'DLL3', 'HEY1', 'AKT3', 'E2F1', 'HRAS', 'FGF22', 'SKP1', 'NCOA1', 'WNT10B', 'WNT10A', 'CSNK2A1', 'PARP1', 'GADD45A', 'BRAF', 'PIK3CA', 'BAX', 'SOS1', 'SOS2', 'FGF10']",0.9982792556030828,0,0,25
216,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4595670406491738,1.1405169575238723,0.8867182307171243,"['NFKBIA', 'NDUFA13', 'HSP90AA1', 'ERBIN', 'RAC1', 'IKBKG']",0.9982792556030828,0,0,6
217,Tumor suppressor activity of SMARCB1 WP4204,0.4595670406491738,1.1405169575238723,0.8867182307171243,"['SMARCD1', 'SMARCD3', 'RBBP4', 'H3F3B', 'DPF2', 'ARID1B']",0.9982792556030828,0,0,6
218,Cysteine and methionine catabolism WP4504,0.47372984642966354,1.2441387559808612,0.929518538726035,"['GOT1', 'GSS', 'SUOX']",0.9982792556030828,0,0,3
219,Galanin receptor pathway WP4970,0.47372984642966354,1.2441387559808612,0.929518538726035,"['PRKCD', 'PPARG', 'VAMP2']",0.9982792556030828,0,0,3
220,Leptin Insulin Overlap WP3935,0.47372984642966354,1.2441387559808612,0.929518538726035,"['IRS1', 'PIK3R3', 'JAK2']",0.9982792556030828,0,0,3
221,Phytochemical activity on NRF2 transcriptional activation WP3,0.47372984642966354,1.2441387559808612,0.929518538726035,"['AIMP2', 'MAF', 'PIK3CA']",0.9982792556030828,0,0,3
222,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.47579161858248514,1.0677033627126256,0.7930636820156315,"['GSK3B', 'ACTR2', 'MAP2K4', 'ACTA1', 'TMSB4X', 'NEFL', 'TGFA', 'SOS1', 'RHOA', 'PFN2', 'SOD1']",0.9982792556030828,0,0,11
223,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.4766736490743495,1.1011539684703102,0.815870517712656,"['GABRB1', 'PIK3CA', 'GABRA3', 'PTEN', 'PIK3R3', 'JAK2', 'RHOA']",0.9982792556030828,0,0,7
224,Modulators of TCR signaling and T cell activation WP5072,0.48900327670231764,1.0608883674924665,0.7589447797751688,"['GNA13', 'NFKBIA', 'ZAP70', 'FIBP', 'NDUFB10', 'ELOB', 'IKBKG', 'RNF7', 'MEF2D', 'NFKB1']",0.9982792556030828,0,0,10
225,Zinc homeostasis WP3529,0.4935297380886794,1.0948172538689496,0.7731294675674744,"['SLC30A3', 'SLC39A10', 'SLC39A7', 'SLC39A1', 'SLC39A4', 'SLC39A3']",0.9982792556030828,0,0,6
226,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.49663541099961955,1.1404244817374136,0.7981820701698589,"['B3GALNT1', 'SGPL1', 'GALNT16', 'ST6GALNAC3']",0.9982792556030828,0,0,4
227,Methionine De Novo and Salvage Pathway WP3580,0.49663541099961955,1.1404244817374136,0.7981820701698589,"['ODC1', 'TXN', 'ENOPH1', 'SRM']",0.9982792556030828,0,0,4
228,Purine metabolism and related disorders WP4224,0.49663541099961955,1.1404244817374136,0.7981820701698589,"['DGUOK', 'GRM5', 'ITPA', 'APRT']",0.9982792556030828,0,0,4
229,Triacylglyceride synthesis WP325,0.49663541099961955,1.1404244817374136,0.7981820701698589,"['DGAT2', 'LPL', 'AGPAT1', 'PLPP1']",0.9982792556030828,0,0,4
230,Urea cycle and metabolism of amino groups WP497,0.49663541099961955,1.1404244817374136,0.7981820701698589,"['ODC1', 'PYCR1', 'PYCR3', 'SRM']",0.9982792556030828,0,0,4
231,Vitamin D in inflammatory diseases WP4482,0.49663541099961955,1.1404244817374136,0.7981820701698589,"['NFKBIA', 'IKBKG', 'NR3C1', 'NFKB1']",0.9982792556030828,0,0,4
232,NRF2 pathway WP2884,0.49947368277740345,1.02509970376923,0.7116245930426481,"['CBR1', 'ABCC4', 'G6PD', 'HSP90AA1', 'HSP90AB1', 'GPX3', 'MGST3', 'TGFA', 'SLC39A10', 'NRG1', 'TXN', 'SLC5A3', 'CES4A', 'GSTA4', 'FTH1', 'SLC39A7', 'SLC39A1', 'SQSTM1', 'SLC39A4', 'SLC39A3']",0.9982792556030828,0,0,20
233,15q11.2 copy number variation syndrome WP4940,0.5007054396580821,1.3033306713017334,0.9015624338372774,"['CYFIP1', 'TUBGCP4']",0.9982792556030828,0,0,2
234,ATR Signaling WP3875,0.5007054396580821,1.3033306713017334,0.9015624338372774,"['CHEK1', 'RAD1']",0.9982792556030828,0,0,2
235,Biotin Metabolism (including IEMs) WP5031,0.5007054396580821,1.3033306713017334,0.9015624338372774,"['ACACB', 'ACACA']",0.9982792556030828,0,0,2
236,"Degradation pathway of sphingolipids, including diseases WP4153",0.5007054396580821,1.3033306713017334,0.9015624338372774,"['NEU3', 'GM2A']",0.9982792556030828,0,0,2
237,Leptin and adiponectin WP3934,0.5007054396580821,1.3033306713017334,0.9015624338372774,"['PRKAG1', 'ACACA']",0.9982792556030828,0,0,2
238,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5007054396580821,1.3033306713017334,0.9015624338372774,"['E2F1', 'BAX']",0.9982792556030828,0,0,2
239,NLR Proteins WP288,0.5007054396580821,1.3033306713017334,0.9015624338372774,"['ERBIN', 'IKBKG']",0.9982792556030828,0,0,2
240,Role of Osx and miRNAs in tooth development WP3971,0.5007054396580821,1.3033306713017334,0.9015624338372774,"['NOTCH4', 'ALPL']",0.9982792556030828,0,0,2
241,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5007054396580821,1.3033306713017334,0.9015624338372774,"['CCND2', 'MEF2D']",0.9982792556030828,0,0,2
242,Thiamine metabolic pathways WP4297,0.5007054396580821,1.3033306713017334,0.9015624338372774,"['BCKDHA', 'SLC25A19']",0.9982792556030828,0,0,2
243,IL-4 signaling pathway WP395,0.5035390312776404,1.0526849551239794,0.7222408841426153,"['NFKBIA', 'PIK3CA', 'IRS1', 'STAT1', 'PIK3CD', 'JAK2', 'SOS1', 'JAK3', 'NFKB1']",0.9982792556030828,0,0,9
244,7-oxo-C and 7beta-HC pathways WP5064,0.5133722801990981,1.08608420326656,0.724150991863897,"['HSD11B2', 'ACOT8', 'ACOT7', 'ACOT13', 'SLC27A5']",0.9982792556030828,0,0,5
245,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5133722801990981,1.08608420326656,0.724150991863897,"['TTC9', 'PNCK', 'TPM3', 'NR3C1', 'JAK2']",0.9982792556030828,0,0,5
246,SARS-CoV-2 mitochondrial interactions WP5038,0.5133722801990981,1.08608420326656,0.724150991863897,"['TOMM70', 'CTSL', 'PHB', 'ECSIT', 'NFKB1']",0.9982792556030828,0,0,5
247,White fat cell differentiation WP4149,0.5133722801990981,1.08608420326656,0.724150991863897,"['WNT10B', 'DDIT3', 'RORA', 'PPARG', 'NR3C1']",0.9982792556030828,0,0,5
248,Prader-Willi and Angelman Syndrome WP3998,0.5145686270736806,1.0367023349219195,0.6888123449541124,"['KISS1', 'PCSK1', 'CYFIP1', 'NHLH2', 'SLC45A2', 'CCND2', 'SNRPN', 'FEZ1', 'E2F1', 'BBS4']",0.9982792556030828,0,0,10
249,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5159780305115106,1.0212149293164297,0.6757288206585591,"['GSK3B', 'THRA', 'ITPR2', 'TTF1', 'TBC1D4', 'PIK3CA', 'AKT3', 'NPPA', 'ITGAV', 'PPARG', 'PRKACA', 'SOS1', 'MAP4K5', 'HRAS', 'MGLL']",0.9982792556030828,0,0,15
250,Regulation of Actin Cytoskeleton WP51,0.5186752105573389,1.0091369188995818,0.6624755709247884,"['PXN', 'PIK3R3', 'BRK1', 'PIK3CD', 'ACTG1', 'CDC42', 'GNA13', 'RRAS', 'TMSB4X', 'CFL1', 'PIP5K1B', 'RAC1', 'FGF22', 'PDGFRB', 'BRAF', 'ARPC5', 'RHOA', 'FGF14', 'MRAS', 'PIK3CA', 'SOS1', 'FGF12', 'SOS2', 'FGF10', 'ARHGEF6']",0.9982792556030828,0,0,25
251,Blood Clotting Cascade WP272,0.5227834435016107,1.1403782894736842,0.7396356359572516,"['F8', 'F11', 'KLKB1']",0.9982792556030828,0,0,3
252,Hypertrophy Model WP516,0.5227834435016107,1.1403782894736842,0.7396356359572516,"['ZEB1', 'IL1R1', 'ADAM10']",0.9982792556030828,0,0,3
253,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.5227834435016107,1.1403782894736842,0.7396356359572516,"['GSK3B', 'RHOA', 'MAP3K4']",0.9982792556030828,0,0,3
254,Overview of nanoparticle effects WP3287,0.5227834435016107,1.1403782894736842,0.7396356359572516,"['AKT3', 'PIK3CD', 'BAX']",0.9982792556030828,0,0,3
255,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5227834435016107,1.1403782894736842,0.7396356359572516,"['GSK3B', 'TNKS', 'TCF4']",0.9982792556030828,0,0,3
256,TP53 network WP1742,0.5227834435016107,1.1403782894736842,0.7396356359572516,"['SUMO1', 'GADD45A', 'BAX']",0.9982792556030828,0,0,3
257,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.5284611238503555,1.013609185283005,0.6464657841222151,"['GSK3B', 'MAP2K4', 'PRKCB', 'PIK3CD', 'PIK3R3', 'NRG1', 'RHOA', 'NFKB1', 'IGF1R', 'PIK3CA', 'NPPA', 'RAC1', 'IKBKG', 'CALM2']",0.9982792556030828,0,0,14
258,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5376551799024719,1.073263263844531,0.6660004823651472,"['G6PD', 'PARP1', 'GOT1', 'MDH2']",0.9982792556030828,0,0,4
259,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5379941300198302,1.029963024352926,0.6384819370266644,"['MAP2K4', 'ACTA1', 'PARP1', 'CASP6', 'CYCS', 'SPTAN1', 'ACTG1']",0.9982792556030828,0,0,7
260,Prostaglandin Synthesis and Regulation WP98,0.5379941300198302,1.029963024352926,0.6384819370266644,"['HSD11B2', 'CBR1', 'ABCC4', 'ANXA6', 'S100A6', 'PPARG', 'PTGES']",0.9982792556030828,0,0,7
261,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5397308237733648,1.0135912371322855,0.6250662467099992,"['ACAN', 'THRA', 'STAT1', 'COL10A1', 'ALPL', 'PRKACA', 'SLC38A2', 'CALM2', 'IGF1R', 'SOX5']",0.9982792556030828,0,0,10
262,Endochondral Ossification WP474,0.5397308237733648,1.0135912371322855,0.6250662467099992,"['ACAN', 'THRA', 'STAT1', 'COL10A1', 'ALPL', 'PRKACA', 'SLC38A2', 'CALM2', 'IGF1R', 'SOX5']",0.9982792556030828,0,0,10
263,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.5475269310793363,1.5204909051062898,0.9158580101225173,['NFKB1'],0.9982792556030828,0,0,1
264,Aflatoxin B1 metabolism WP699,0.5475269310793363,1.5204909051062898,0.9158580101225173,['AKR7A2'],0.9982792556030828,0,0,1
265,Gastric acid production WP2596,0.5475269310793363,1.5204909051062898,0.9158580101225173,['GRP'],0.9982792556030828,0,0,1
266,Hypothetical Craniofacial Development Pathway WP3655,0.5475269310793363,1.5204909051062898,0.9158580101225173,['RHOA'],0.9982792556030828,0,0,1
267,MED and Pseudoachondroplasia genes WP4789,0.5475269310793363,1.5204909051062898,0.9158580101225173,['COL9A3'],0.9982792556030828,0,0,1
268,Nanomaterial-induced inflammasome activation WP3890,0.5475269310793363,1.5204909051062898,0.9158580101225173,['NFKB1'],0.9982792556030828,0,0,1
269,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.5475269310793363,1.5204909051062898,0.9158580101225173,['CCKBR'],0.9982792556030828,0,0,1
270,Steroid Biosynthesis WP496,0.5475269310793363,1.5204909051062898,0.9158580101225173,['HSD17B1'],0.9982792556030828,0,0,1
271,Vitamin B6-dependent and responsive disorders WP4228,0.5475269310793363,1.5204909051062898,0.9158580101225173,['PIGV'],0.9982792556030828,0,0,1
272,Gastric Cancer Network 2 WP2363,0.5492799643149222,1.0366419294990723,0.6211009168951177,"['OTUD5', 'AHCTF1', 'S100A6', 'BRIX1', 'COL9A3']",0.9982792556030828,0,0,5
273,DNA IR-damage and cellular response via ATR WP4016,0.549505596925622,0.9976993232089799,0.5973588209477146,"['MDC1', 'FEN1', 'PARP1', 'RMI1', 'RPA2', 'PPM1D', 'CHEK1', 'E2F1', 'CDK1', 'RAD1', 'IKBKG', 'CLSPN', 'EEF1E1', 'MCPH1']",0.9982792556030828,0,0,14
274,Circadian rhythm related genes WP3594,0.5541660375115528,0.9886235942012834,0.5835755412744118,"['GSK3B', 'SUV39H1', 'PTEN', 'RORA', 'ADCY1', 'ATOH7', 'AANAT', 'DRD1', 'RPS27A', 'SKP1', 'PRKCG', 'PRMT5', 'NCOA2', 'KCND2', 'CAVIN3', 'DYRK1A', 'PROX1', 'CARTPT', 'MAPK10', 'PER3', 'STAR', 'MYBBP1A', 'PSPC1', 'CRY2', 'CRH', 'PPARG', 'TOP1', 'ATF5', 'CLOCK', 'UBA52', 'ATF4']",0.9982792556030828,0,0,31
275,Wnt Signaling Pathway WP363,0.5565059940156435,1.0011897679952408,0.5867746334657279,"['PRKCG', 'GSK3B', 'PRKCB', 'PPARG', 'ROR1', 'PIP5K1B', 'TCF4', 'RAC1', 'RHOA']",0.9982792556030828,0,0,9
276,Endoderm differentiation WP2853,0.5588594093638923,0.9873368493589962,0.5744891941165177,"['VAV3', 'STAT1', 'SIAH2', 'CTR9', 'NCAPG2', 'RTF1', 'LAMC1', 'NR3C1', 'PHF6', 'ACACA', 'PARP8', 'NME1', 'RFX7', 'SESN1', 'SP4', 'TCEAL2', 'UBR5', 'NABP2', 'TCF4', 'ASCC3', 'JARID2']",0.9982792556030828,0,0,21
277,EDA signaling in hair follicle development WP3930,0.5603169935686496,1.1403321275896088,0.6605403445931849,"['EDA', 'LTB']",0.9982792556030828,0,0,2
278,Non-homologous end joining WP438,0.5603169935686496,1.1403321275896088,0.6605403445931849,"['XRCC6', 'POLL']",0.9982792556030828,0,0,2
279,Glycogen Synthesis and Degradation WP500,0.5675385155023721,0.9977046277997365,0.5651464572792623,"['GYS2', 'GSK3B', 'PPP2CB', 'PPP2R5A', 'PHKA1', 'CALM3', 'CALM2']",0.9982792556030828,0,0,7
280,Cancer immunotherapy by PD-1 blockade WP4585,0.5692066031919115,1.052580971659919,0.5931418106216965,"['ZAP70', 'NFKB1', 'HLA-DRB1']",0.9982792556030828,0,0,3
281,MAPK pathway in congenital thyroid cancer WP4928,0.5692066031919115,1.052580971659919,0.5931418106216965,"['BRAF', 'SOS1', 'SOS2']",0.9982792556030828,0,0,3
282,NAD+ metabolism WP3644,0.5692066031919115,1.052580971659919,0.5931418106216965,"['NT5E', 'PARP1', 'NADK']",0.9982792556030828,0,0,3
283,1q21.1 copy number variation syndrome WP4905,0.5769064272352563,1.0135644034953017,0.5575366387166828,"['TJP1', 'PYGO2', 'AFDN', 'PRKAG1']",0.9982792556030828,0,0,4
284,Constitutive Androstane Receptor Pathway WP2875,0.5769064272352563,1.0135644034953017,0.5575366387166828,"['NCOA1', 'NCOA2', 'HSP90AA1', 'DNAJC7']",0.9982792556030828,0,0,4
285,Nanoparticle triggered autophagic cell death WP2509,0.5769064272352563,1.0135644034953017,0.5575366387166828,"['BECN1', 'UVRAG', 'MAP1LC3A', 'ATG9B']",0.9982792556030828,0,0,4
286,PKC-gamma calcium signaling pathway in ataxia WP4760,0.5769064272352563,1.0135644034953017,0.5575366387166828,"['PRKCG', 'PLCB4', 'CA8', 'PDK1']",0.9982792556030828,0,0,4
287,Adipogenesis WP236,0.5815817760163837,0.9735226799833542,0.5276528823924259,"['NCOA1', 'WNT10B', 'NCOA2', 'MBNL1', 'IRS1', 'GADD45A', 'STAT1', 'CISD1', 'LPL', 'RORA', 'NR3C1', 'CYP26B1', 'KLF6', 'DDIT3', 'E2F1', 'SPOCK1', 'PPARG', 'MEF2D', 'LPIN3']",0.9982792556030828,0,0,19
288,RANKL/RANK signaling pathway WP2018,0.5821061829125893,0.977281288256898,0.528809253506929,"['CDC42', 'NFKBIA', 'STAT1', 'TRAF5', 'TAB2', 'RAC1', 'IKBKG', 'SQSTM1', 'NFKB1']",0.9982792556030828,0,0,9
289,Joubert Syndrome WP4656,0.584649620652203,0.9718876805713358,0.5216534722186325,"['PARP1', 'CETN2', 'ARL3', 'RHOA', 'AHI1', 'NIN', 'TMEM17', 'CSPP1', 'BBS9', 'CEP41', 'RAB8A', 'BBS4', 'ATF4']",0.9982792556030828,0,0,13
290,Parkinson's disease pathway WP2371,0.5902373062060056,0.9773037301848628,0.5152644408826431,"['CASP6', 'SYT11', 'CASP2', 'CYCS', 'PARK7', 'UBE2J2']",0.9982792556030828,0,0,6
291,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5914973614530633,0.9684505506423917,0.5085315018096784,"['MAP2K4', 'WNT10B', 'GSK3B', 'WNT10A', 'PDCD6', 'NOTCH4', 'PIK3R3', 'PIK3CD', 'PROX1', 'NR2C2', 'DLL3', 'TJP1', 'ZEB2', 'ZEB1', 'FMNL2', 'PIK3CA', 'RBBP4', 'AKT3', 'PKP1', 'STRAP', 'SOS1', 'HRAS', 'SOS2', 'MEF2D']",0.9982792556030828,0,0,24
292,Mesodermal commitment pathway WP2857,0.5923021718618184,0.967250265728095,0.5065860571248445,"['HES7', 'VAV3', 'NCAPG2', 'ARID5B', 'PHF6', 'ACACA', 'PARP8', 'ARL4A', 'WDCP', 'PRKAR1A', 'SESN1', 'UBR5', 'NABP2', 'CCDC6', 'RPL38', 'TCF4', 'ASCC3', 'PRKACA', 'JAK2', 'JARID2', 'TEAD1']",0.9982792556030828,0,0,21
293,Pathways affected in adenoid cystic carcinoma WP3651,0.5944983384153717,0.9646907347270144,0.5016752207652667,"['KDM6B', 'PIK3CA', 'KAT6A', 'CHEK1', 'ATRX', 'PTEN', 'ERBIN', 'ARID5B', 'ARID4B', 'DTX4', 'HRAS']",0.9982792556030828,0,0,11
294,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5944983384153717,0.9646907347270144,0.5016752207652667,"['ITGB1', 'NFKBIA', 'PIK3CA', 'STMN1', 'PXN', 'BAX', 'RAC1', 'IKBKG', 'SOS1', 'HRAS', 'NFKB1']",0.9982792556030828,0,0,11
295,Nephrotic syndrome WP4758,0.5961757894131781,0.9674012855831038,0.500359009215425,"['CUBN', 'ANLN', 'INF2', 'ARHGDIA', 'TTC21B', 'MYH9', 'CD2AP']",0.9982792556030828,0,0,7
296,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5961757894131781,0.9674012855831038,0.500359009215425,"['NFKBIA', 'CAMK2A', 'NPPA', 'NEFL', 'CYCS', 'CALM2', 'NFKB1']",0.9982792556030828,0,0,7
297,BMP Signaling Pathway in Eyelid Development WP3927,0.6127213973212662,0.9773261278195489,0.47873825537503983,"['TGFA', 'DKK2', 'FGF10']",0.9982792556030828,0,0,3
298,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6127213973212662,0.9773261278195489,0.47873825537503983,"['CYP24A1', 'ALPL', 'NFKB1']",0.9982792556030828,0,0,3
299,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6127213973212662,0.9773261278195489,0.47873825537503983,"['TJP1', 'PXN', 'ITGAV']",0.9982792556030828,0,0,3
300,PPAR-alpha pathway WP2878,0.6127213973212662,0.9773261278195489,0.47873825537503983,"['CPT2', 'CDK1', 'APOA1']",0.9982792556030828,0,0,3
301,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6141825182477829,0.9601496337091495,0.46803754957449467,"['TGFBR3', 'NR2C2', 'LTBP1', 'FBN1']",0.9982792556030828,0,0,4
302,TLR4 Signaling and Tolerance WP3851,0.6141825182477829,0.9601496337091495,0.46803754957449467,"['NFKBIA', 'TAB2', 'IKBKG', 'NFKB1']",0.9982792556030828,0,0,4
303,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['BATF3', 'TCF4']",0.9982792556030828,0,0,2
304,Farnesoid X receptor pathway WP2879,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['SLC27A5', 'FKBP5']",0.9982792556030828,0,0,2
305,Glycolysis in senescence WP5049,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['G6PD', 'PGK1']",0.9982792556030828,0,0,2
306,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['IDI1', 'PMVK']",0.9982792556030828,0,0,2
307,Osteoblast Signaling WP322,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['PDGFRB', 'ITGAV']",0.9982792556030828,0,0,2
308,Osteopontin Signaling WP1434,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['ITGAV', 'NFKB1']",0.9982792556030828,0,0,2
309,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['ZAP70', 'HLA-DRB1']",0.9982792556030828,0,0,2
310,Sulfation Biotransformation Reaction WP692,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['G6PD', 'SULT4A1']",0.9982792556030828,0,0,2
311,Transcriptional cascade regulating adipogenesis WP4211,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['DDIT3', 'PPARG']",0.9982792556030828,0,0,2
312,Vitamin B12 Disorders WP4271,0.6146421122939446,1.0135554824801782,0.49331276996341683,"['CUBN', 'MMACHC']",0.9982792556030828,0,0,2
313,Autophagy WP4923,0.6169343416400084,0.9501179504059688,0.4589000116041555,"['BECN1', 'UVRAG', 'MAP1LC3B', 'PRKAG1', 'WIPI2']",0.9982792556030828,0,0,5
314,Splicing factor NOVA regulated synaptic proteins WP4148,0.6238078421059848,0.9388804929086259,0.44306981933590533,"['PLCB4', 'CADM1', 'EPB41', 'CLSTN1', 'GRIK2', 'EFNA5', 'NEO1']",0.9982792556030828,0,0,7
315,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6246953475497381,0.9479591903598037,0.44600644944501183,"['CAP1', 'MAP2K4', 'GSK3B', 'THRA', 'IRS1', 'PRKAG1', 'LPL', 'PIK3R3', 'PIK3CD', 'MAPK10', 'RPS6KA5', 'SESN3', 'PIK3CA', 'RPS6KA2', 'RICTOR', 'SOS1', 'MAP4K5', 'HRAS', 'SOS2', 'MAP3K4', 'MAP4K3']",0.9982792556030828,0,0,21
316,Apoptosis Modulation and Signaling WP1772,0.6257035753924283,0.9408978993137409,0.44116683498110343,"['HRK', 'TNFRSF6B', 'CRADD', 'IL1R1', 'NFKB1', 'NFKBIA', 'CAPNS1', 'CASP6', 'CASP2', 'CYCS', 'BAX', 'BIRC6', 'BCL2L2']",0.9982792556030828,0,0,13
317,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6274670329918434,0.9354116504034131,0.43596183239762804,"['NFKBIA', 'MAPK10', 'MAP2K4', 'RPS6KA5', 'IL1R1', 'TAB2', 'NFKB1', 'NFKBIB']",0.9982792556030828,0,0,8
318,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.6289119820480071,1.1402859960552267,0.5288235550202843,['RAC1'],0.9982792556030828,0,0,1
319,The alternative pathway of fetal androgen synthesis WP4524,0.6289119820480071,1.1402859960552267,0.5288235550202843,['STAR'],0.9982792556030828,0,0,1
320,Ebola Virus Pathway on Host WP4217,0.6326416105754966,0.9415724925235794,0.43110008918829174,"['ITGB1', 'STAT1', 'PIK3R3', 'CLTA', 'PIK3CD', 'EIF2S1', 'NFKB1', 'RHOA', 'IGF1R', 'ACTG1', 'RHOB', 'CDC42', 'PIK3CA', 'CTSL', 'ITGAV', 'RAC1', 'TOP1', 'RAB5A', 'HLA-DRB1']",0.9982792556030828,0,0,19
321,TNF-alpha signaling pathway WP231,0.633979799098514,0.9368722969182606,0.42696848267873333,"['MAP2K4', 'HSP90AA1', 'CSNK2A1', 'TXN', 'NFKB1', 'NFKBIA', 'CDC37', 'BAX', 'TAB2', 'RAC1', 'IKBKG', 'SOS1', 'HRAS', 'SKP1', 'NFKBIB']",0.9982792556030828,0,0,15
322,Wnt signaling WP428,0.6417123815812357,0.9338026262352782,0.4142489262218111,"['PRKCG', 'WNT10B', 'GSK3B', 'WNT10A', 'CSNK2A1', 'PRKCB', 'CAMK2A', 'PRICKLE2', 'CXXC4', 'DKK2', 'RHOA', 'PORCN', 'CCND2', 'SFRP2', 'PLCB4', 'ROR1', 'RAC1']",0.9982792556030828,0,0,17
323,GABA receptor Signaling WP4159,0.6484077772383485,0.9120473996050033,0.395131306344529,"['GABRB1', 'GABBR1', 'GABRA3', 'AP2S1', 'AP2M1']",0.9982792556030828,0,0,5
324,Genes controlling nephrogenesis WP4823,0.6484077772383485,0.9120473996050033,0.395131306344529,"['RET', 'ITGB1', 'PDGFRB', 'ITGA8', 'CD2AP']",0.9982792556030828,0,0,5
325,Pathways in clear cell renal cell carcinoma WP4018,0.6488756237711157,0.9250673441753867,0.40010478407298866,"['PDGFRB', 'PBRM1', 'TPI1', 'PTEN', 'PLOD2', 'ACACB', 'ACACA', 'ZEB1', 'PGK1', 'RAPGEF5', 'ALDOA', 'SQSTM1', 'PFKM', 'PFKP']",0.9982792556030828,0,0,14
326,Physiological and pathological hypertrophy of the heart WP1528,0.6493410218130368,0.9120763409016124,0.3938320493551966,"['PRKCB', 'RAC1', 'CALM2', 'RHOA']",0.9982792556030828,0,0,4
327,Notch Signaling WP268,0.6503553473312579,0.9119894598155468,0.3923710412995325,"['KAT2B', 'NUMBL', 'NCSTN', 'NOTCH4', 'PSEN2', 'DTX4', 'DLL3']",0.9982792556030828,0,0,7
328,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.65225261523826,0.9119604612850082,0.38970199519715526,"['GSK3B', 'PIK3CA', 'AKT3', 'PRKAG1', 'PTEN', 'PIK3CD', 'PIK3R3', 'HRAS']",0.9982792556030828,0,0,8
329,IL1 and megakaryocytes in obesity WP2865,0.6531696011405818,0.9121052631578948,0.3884824666093856,"['PIK3CA', 'IL1R1', 'NFKB1']",0.9982792556030828,0,0,3
330,Nanomaterial induced apoptosis WP2507,0.6531696011405818,0.9121052631578948,0.3884824666093856,"['CASP6', 'BAX', 'CYCS']",0.9982792556030828,0,0,3
331,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6531696011405818,0.9121052631578948,0.3884824666093856,"['SUV39H1', 'CDC37', 'ECSIT']",0.9982792556030828,0,0,3
332,Transcription factor regulation in adipogenesis WP3599,0.6531696011405818,0.9121052631578948,0.3884824666093856,"['IRS1', 'PPARG', 'NR3C1']",0.9982792556030828,0,0,3
333,DNA IR-double strand breaks and cellular response via ATM WP3959,0.654461872867538,0.9119314436387607,0.3866059937166124,"['MDC1', 'RASSF1', 'PARP1', 'CHEK1', 'RNF8', 'E2F1', 'NABP2', 'BAX', 'MCPH1']",0.9982792556030828,0,0,9
334,Complement system WP2806,0.6619997455672338,0.9118442758165622,0.3761267432497239,"['LAMA5', 'FKBP2', 'RPS19', 'F11', 'APOA1', 'CD59', 'TXN', 'CALR', 'LAMC1', 'PRKACA', 'KLKB1', 'ELANE']",0.9982792556030828,0,0,12
335,Genes targeted by miRNAs in adipocytes WP1992,0.6636538923555441,0.912134166392634,0.3739700022958269,"['TMSB4X', 'PTBP2']",0.9982792556030828,0,0,2
336,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6636538923555441,0.912134166392634,0.3739700022958269,"['GABBR1', 'GRM5']",0.9982792556030828,0,0,2
337,Serotonin and anxiety-related events WP3944,0.6636538923555441,0.912134166392634,0.3739700022958269,"['PRKCB', 'CRH']",0.9982792556030828,0,0,2
338,IL-3 signaling pathway WP286,0.675756861776526,0.8865923730054165,0.3474750024316863,"['YWHAQ', 'YWHAB', 'PIK3CD', 'JAK2', 'PRKACA', 'SOS1', 'HRAS']",0.9982792556030828,0,0,7
339,Development of ureteric collection system WP5053,0.6763100454393174,0.8825347594718898,0.34516257537687545,"['RET', 'ITGB1', 'GRIP1', 'FRAS1', 'GREB1L', 'ITGA8']",0.9982792556030828,0,0,6
340,Oxidative Damage WP3941,0.6763100454393174,0.8825347594718898,0.34516257537687545,"['CDC42', 'MAPK10', 'MAP2K4', 'GADD45A', 'CYCS', 'NFKB1']",0.9982792556030828,0,0,6
341,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6763100454393174,0.8825347594718898,0.34516257537687545,"['NFKBIA', 'GSK3B', 'TRAF5', 'RAC1', 'NFKB1', 'NFKBIB']",0.9982792556030828,0,0,6
342,Cardiac Progenitor Differentiation WP2406,0.6781919896700062,0.8769053527118044,0.3405241487830181,"['MESP2', 'MESP1', 'GSK3B', 'NRG1', 'SCN5A']",0.9982792556030828,0,0,5
343,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6781919896700062,0.8769053527118044,0.3405241487830181,"['NFKBIA', 'STAT1', 'IKBKG', 'NFKB1', 'IFNAR1']",0.9982792556030828,0,0,5
344,IL-18 signaling pathway WP4754,0.6790642449095415,0.9315181791113905,0.36053436656552906,"['MTCH1', 'GSK3B', 'NRN1', 'TOMM40', 'EPB41', 'CD81', 'HSPB8', 'COX17', 'PTEN', 'ACACB', 'RXRB', 'TMSB4X', 'STMN1', 'NPPA', 'RAE1', 'ABCF1', 'CA11', 'PARP1', 'PRKCB', 'ECH1', 'PRKCD', 'HPS1', 'NDUFC1', 'BPGM', 'NFKB1', 'NFKBIA', 'SLC4A7', 'ARL4D', 'ACTA1', 'ALS2', 'NACA', 'CYCS', 'BAX', 'LTB', 'CDK5R2', 'AARS', 'ITM2C']",0.9982792556030828,0,0,37
345,Monoamine Transport WP727,0.682295835755067,0.8685814569328884,0.33205168885145636,"['PPP2CB', 'IL1R1', 'AMPH', 'STX1A']",0.9982792556030828,0,0,4
346,MAPK Signaling Pathway WP382,0.6845776205593587,0.9304034411360769,0.352579401526754,"['PPP5D1', 'ECSIT', 'STK4', 'CDC42', 'RPS6KA5', 'RAP1A', 'RRAS', 'STMN1', 'AKT3', 'RAC1', 'IKBKG', 'PRKACA', 'HRAS', 'MAP4K3', 'MAP3K4', 'FGF22', 'PRKCG', 'PDGFRB', 'MAP2K4', 'HSPA8', 'IL1R1', 'GADD45A', 'PRKCD', 'PLA2G4C', 'BRAF', 'NFKB1', 'DUSP7', 'MAPK10', 'MRAS', 'FGF14', 'DDIT3', 'RAPGEF2', 'TAB2', 'SOS1', 'FGF12', 'SOS2', 'PTPN5', 'ATF4', 'FGF10']",0.9982792556030828,0,0,39
347,Inflammatory Response Pathway WP453,0.6904903858302468,0.8550370065789473,0.3166657169162835,"['LAMA5', 'ZAP70', 'LAMC1']",0.9982792556030828,0,0,3
348,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6904903858302468,0.8550370065789473,0.3166657169162835,"['NFKBIA', 'IKBKG', 'NFKB1']",0.9982792556030828,0,0,3
349,Regulation of toll-like receptor signaling pathway WP1449,0.6914223021495407,0.9010321400574863,0.3324849102774816,"['OTUD5', 'MAP2K4', 'STAT1', 'PELI2', 'PIK3R3', 'PIK3CD', 'NFKB1', 'NFKBIA', 'MAPK10', 'PIK3CA', 'AKT3', 'TAB2', 'RAC1', 'IKBKG', 'ZMYND11', 'SQSTM1', 'IFNAR1']",0.9982792556030828,0,0,17
350,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.6956624306496499,0.9121630506245891,0.3310155333255432,['PPARG'],0.9982792556030828,0,0,1
351,Fluoroacetic acid toxicity WP4966,0.6956624306496499,0.9121630506245891,0.3310155333255432,['ACSS2'],0.9982792556030828,0,0,1
352,FTO Obesity Variant Mechanism WP3407,0.6956624306496499,0.9121630506245891,0.3310155333255432,['ARID5B'],0.9982792556030828,0,0,1
353,Metastatic brain tumor WP2249,0.6956624306496499,0.9121630506245891,0.3310155333255432,['CDC42'],0.9982792556030828,0,0,1
354,miRNA Biogenesis WP2338,0.6956624306496499,0.9121630506245891,0.3310155333255432,['RAN'],0.9982792556030828,0,0,1
355,Molybdenum cofactor (Moco) biosynthesis WP4507,0.6956624306496499,0.9121630506245891,0.3310155333255432,['SUOX'],0.9982792556030828,0,0,1
356,"Phase I biotransformations, non P450 WP136",0.6956624306496499,0.9121630506245891,0.3310155333255432,['ESD'],0.9982792556030828,0,0,1
357,SARS-CoV-2 and COVID-19 Pathway WP4846,0.6956624306496499,0.9121630506245891,0.3310155333255432,['CTSL'],0.9982792556030828,0,0,1
358,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6999676986360408,0.8625681016985365,0.3076962332724622,"['LAG3', 'STAT1', 'DHX58', 'TRAF5', 'RAE1', 'NFKB1', 'IFNAR1']",0.9982792556030828,0,0,7
359,Ferroptosis WP4313,0.7022442558149831,0.8548938096806059,0.3021827282576914,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'GSS', 'VDAC2']",0.9982792556030828,0,0,6
360,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7075060026213135,0.8291530895937341,0.2868945683784752,"['RYR2', 'CCKBR']",0.9982792556030828,0,0,2
361,Ganglio Sphingolipid Metabolism WP1423,0.7075060026213135,0.8291530895937341,0.2868945683784752,"['ST8SIA1', 'ST3GAL5']",0.9982792556030828,0,0,2
362,Hedgehog Signaling Pathway Netpath WP47,0.7075060026213135,0.8291530895937341,0.2868945683784752,"['STK36', 'SAP18']",0.9982792556030828,0,0,2
363,IL-9 signaling pathway WP22,0.7075060026213135,0.8291530895937341,0.2868945683784752,"['STAT1', 'JAK3']",0.9982792556030828,0,0,2
364,Nephrogenesis WP5052,0.7075060026213135,0.8291530895937341,0.2868945683784752,"['GREB1L', 'RSPO3']",0.9982792556030828,0,0,2
365,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.7075060026213135,0.8291530895937341,0.2868945683784752,"['UBE2V1', 'NFKB1']",0.9982792556030828,0,0,2
366,Signal transduction through IL1R WP4496,0.713009178221593,0.8290406533249574,0.28043210880261227,"['NFKBIA', 'IL1R1', 'ECSIT', 'NFKB1']",0.9982792556030828,0,0,4
367,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7205355708840198,0.8481514118233018,0.27799052660820783,"['VAV3', 'HELLS', 'BEX3', 'SERBP1', 'NRG1', 'RNF7', 'SQSTM1', 'NFKB1']",0.9982792556030828,0,0,8
368,Phosphodiesterases in neuronal function WP4222,0.7205355708840198,0.8481514118233018,0.27799052660820783,"['PDE11A', 'ADCY9', 'PDE10A', 'PDE6H', 'PDE4D', 'ADCY1', 'DRD1', 'ADCY7']",0.9982792556030828,0,0,8
369,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7247000494028865,0.8046826625386997,0.2591057530824384,"['H3F3B', 'H2AFY', 'H2AFZ']",0.9982792556030828,0,0,3
370,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7247000494028865,0.8046826625386997,0.2591057530824384,"['GSK3B', 'CYP24A1', 'PIK3CA']",0.9982792556030828,0,0,3
371,BDNF-TrkB Signaling WP3676,0.732525461759594,0.8141516975453776,0.2534105603415086,"['GAB1', 'BRAF', 'ADCY1', 'SOS1', 'HRAS']",0.9982792556030828,0,0,5
372,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.732525461759594,0.8141516975453776,0.2534105603415086,"['IGFBP2', 'PGK1', 'TGFA', 'BAX', 'HIF1AN']",0.9982792556030828,0,0,5
373,DNA damage response WP707,0.7370852660525239,0.844109853341637,0.25749714580101646,"['CCND2', 'GADD45A', 'SESN1', 'CHEK1', 'E2F1', 'CDK1', 'RPA2', 'CYCS', 'BAX', 'RAD1']",0.9982792556030828,0,0,10
374,Cardiac Hypertrophic Response WP2795,0.7411767709134821,0.8288153362288453,0.24824355776340942,"['GSK3B', 'MAP2K4', 'NPPA', 'NRG1', 'RAC1', 'IKBKG', 'CALM2', 'NFKB1']",0.9982792556030828,0,0,8
375,Monoamine GPCRs WP58,0.7414837917927461,0.7929381804655422,0.23716937687500927,"['HTR1E', 'ADRA1D', 'DRD1', 'HTR5A']",0.9982792556030828,0,0,4
376,Type II interferon signaling (IFNG) WP619,0.7414837917927461,0.7929381804655422,0.23716937687500927,"['STAT1', 'PRKCD', 'ISG15', 'JAK2']",0.9982792556030828,0,0,4
377,Histone Modifications WP2369,0.744714521666147,0.8182156008242965,0.24117258829873772,"['KMT2E', 'SET', 'H3F3B', 'SUV39H1', 'EHMT2', 'HIST1H4C', 'HIST1H4E']",0.9982792556030828,0,0,7
378,Proximal tubule transport WP4917,0.744714521666147,0.8182156008242965,0.24117258829873772,"['ABCC4', 'ATP6V1G1', 'SLC47A1', 'SLC4A2', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9982792556030828,0,0,7
379,Airway smooth muscle cell contraction WP4962,0.7464686464177188,0.7600021922613176,0.22222590540622938,"['CALM2', 'RHOA']",0.9982792556030828,0,0,2
380,Cell Differentiation - Index expanded WP2023,0.7464686464177188,0.7600021922613176,0.22222590540622938,"['PAX7', 'MEF2D']",0.9982792556030828,0,0,2
381,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7464686464177188,0.7600021922613176,0.22222590540622938,"['COL5A1', 'TEAD1']",0.9982792556030828,0,0,2
382,Riboflavin and CoQ disorders WP5037,0.7464686464177188,0.7600021922613176,0.22222590540622938,"['FLAD1', 'COQ7']",0.9982792556030828,0,0,2
383,Benzo(a)pyrene metabolism WP696,0.750409147687885,0.7600810870041639,0.21824716817514228,['AKR1A1'],0.9982792556030828,0,0,1
384,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.750409147687885,0.7600810870041639,0.21824716817514228,['NSDHL'],0.9982792556030828,0,0,1
385,Glial Cell Differentiation WP2276,0.750409147687885,0.7600810870041639,0.21824716817514228,['GAP43'],0.9982792556030828,0,0,1
386,Ketogenesis and Ketolysis WP4742,0.750409147687885,0.7600810870041639,0.21824716817514228,['CPT2'],0.9982792556030828,0,0,1
387,Mevalonate pathway WP3963,0.750409147687885,0.7600810870041639,0.21824716817514228,['PMVK'],0.9982792556030828,0,0,1
388,Type III interferon signaling WP2113,0.750409147687885,0.7600810870041639,0.21824716817514228,['STAT1'],0.9982792556030828,0,0,1
389,Spinal Cord Injury WP2431,0.7507592140741066,0.8544625165125496,0.24494902512287584,"['EPHA4', 'IL1R1', 'GADD45A', 'NCAN', 'PLA2G6', 'RHOA', 'RHOB', 'CDC42', 'ACAN', 'GAP43', 'APEX1', 'CDK1', 'E2F1', 'RAC1', 'LTB']",0.9982792556030828,0,0,15
390,ESC Pluripotency Pathways WP3931,0.7508369263680881,0.8577858100623797,0.24581292848460454,"['PDGFRB', 'WNT10B', 'GSK3B', 'ACTR2', 'WNT10A', 'PTEN', 'GAB1', 'PIK3CD', 'BRAF', 'FGF14', 'AKT3', 'SOS1', 'FGF12', 'HRAS', 'FGF22', 'FGF10']",0.9982792556030828,0,0,16
391,Head and Neck Squamous Cell Carcinoma WP4674,0.7532987297545379,0.8355815743183818,0.23671475385026047,"['PIK3CA', 'TERT', 'SESN1', 'AKT3', 'PTEN', 'GAB1', 'E2F1', 'RICTOR', 'HRAS', 'NFKB1', 'IGF1R']",0.9982792556030828,0,0,11
392,IL-7 signaling pathway WP205,0.7558741552318241,0.7599232456140351,0.2126876052276642,"['GSK3B', 'STAT1', 'JAK3']",0.9982792556030828,0,0,3
393,Immune response to tuberculosis WP4197,0.7558741552318241,0.7599232456140351,0.2126876052276642,"['STAT1', 'JAK2', 'IFNAR1']",0.9982792556030828,0,0,3
394,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7558741552318241,0.7599232456140351,0.2126876052276642,"['GSK3B', 'BAX', 'BCL2L2']",0.9982792556030828,0,0,3
395,Microglia Pathogen Phagocytosis Pathway WP3937,0.7570578737515135,0.786020748677669,0.21876181821151036,"['VAV3', 'PIK3CA', 'PIK3R3', 'PIK3CD', 'RAC1']",0.9982792556030828,0,0,5
396,Target Of Rapamycin (TOR) Signaling WP1471,0.7570578737515135,0.786020748677669,0.21876181821151036,"['CDC42', 'IDI1', 'PRKAG1', 'RICTOR', 'RAC1']",0.9982792556030828,0,0,5
397,Tryptophan metabolism WP465,0.7570578737515135,0.786020748677669,0.21876181821151036,"['ECHS1', 'AANAT', 'WARS', 'AFMID', 'CAT']",0.9982792556030828,0,0,5
398,Genes related to primary cilium development (based on CRISPR) WP4536,0.7648904719521448,0.8477500941142124,0.22721620923477864,"['MKKS', 'IFT140', 'ARL3', 'TUBD1', 'DYNLL1', 'TXNDC15', 'IFT20', 'TMEM17', 'KIF3B', 'BBS12', 'TTC21B', 'TMEM107', 'SASS6', 'IFT27', 'BBS9', 'BBS4']",0.9982792556030828,0,0,16
399,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7652328088884732,0.7977025691699605,0.21344539745103408,"['TGFBR3', 'ZEB2', 'STAT1', 'HRAS', 'LTBP1', 'NFKB1', 'FBN1']",0.9982792556030828,0,0,7
400,TGF-beta Signaling Pathway WP366,0.7654087178545653,0.8596358733982861,0.2298196243239919,"['ITGB1', 'MAP2K4', 'SMURF2', 'WWP1', 'RHOA', 'RBX1', 'TGFBR3', 'CDC42', 'ZEB2', 'KLF6', 'ZEB1', 'TERT', 'SUMO1', 'CDK1', 'SNIP1', 'STRAP', 'RAC1', 'SOS1', 'PDK1', 'SKP1']",0.9982792556030828,0,0,20
401,Integrated breast cancer pathway WP1984,0.7670749625432698,0.8659460346997975,0.22962355744903384,"['IRS1', 'RALGAPA1', 'GADD45A', 'STAT1', 'ZMYND8', 'DCAKD', 'ODC1', 'PTEN', 'BRAF', 'PHB', 'JAKMIP1', 'CCNB1IP1', 'NFKB1', 'CDC42', 'FER', 'RAP1A', 'RRAS', 'CHEK1', 'E2F1', 'RHO', 'BAX', 'RAC1', 'FAU']",0.9982792556030828,0,0,23
402,Acute viral myocarditis WP4298,0.7721019302223614,0.8138453205218784,0.21049189871720755,"['GSK3B', 'PARP1', 'CASP6', 'STAT1', 'CASP2', 'ABL2', 'CYCS', 'BAX', 'SOS1', 'EIF4G2']",0.9982792556030828,0,0,10
403,miRNA regulation of DNA damage response WP1530,0.7721019302223614,0.8138453205218784,0.21049189871720755,"['CCND2', 'GADD45A', 'SESN1', 'CHEK1', 'E2F1', 'CDK1', 'RPA2', 'CYCS', 'BAX', 'RAD1']",0.9982792556030828,0,0,10
404,Bladder cancer WP2828,0.7798596870151753,0.7597651964011412,0.18890897871746748,"['RASSF1', 'RPS6KA5', 'E2F1', 'BRAF', 'HRAS']",0.9982792556030828,0,0,5
405,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7798596870151753,0.7597651964011412,0.18890897871746748,"['MAPK10', 'MAP2K4', 'RPS6KA2', 'DDIT3', 'MAP3K4']",0.9982792556030828,0,0,5
406,Dopaminergic Neurogenesis WP2855,0.7808817043644748,0.7014898945185035,0.17350062325457818,"['RET', 'ASCL1']",0.9982792556030828,0,0,2
407,ERK Pathway in Huntington's Disease WP3853,0.7808817043644748,0.7014898945185035,0.17350062325457818,"['RPS6KA5', 'HRAS']",0.9982792556030828,0,0,2
408,Type II diabetes mellitus WP1584,0.7808817043644748,0.7014898945185035,0.17350062325457818,"['IRS1', 'PRKCD']",0.9982792556030828,0,0,2
409,Statin inhibition of cholesterol production WP430,0.7841321775109814,0.7198753462603878,0.17505761592911143,"['SOAT1', 'LPL', 'APOA1']",0.9982792556030828,0,0,3
410,Urea cycle and associated pathways WP4595,0.7841321775109814,0.7198753462603878,0.17505761592911143,"['GOT1', 'MDH2', 'PYCR1']",0.9982792556030828,0,0,3
411,Folate Metabolism WP176,0.7845220864025233,0.7781901732060799,0.18885162213979492,"['GPX4', 'FLAD1', 'GPX3', 'CAT', 'APOA1', 'NFKB1', 'SOD1']",0.9982792556030828,0,0,7
412,Integrated Cancer Pathway WP1971,0.7915399957765389,0.7596860937328505,0.17759551728557205,"['STAT1', 'CHEK1', 'PTEN', 'E2F1', 'CDK1', 'BAX']",0.9982792556030828,0,0,6
413,Sphingolipid pathway WP1422,0.791886966784558,0.7293978282329714,0.17019522100092857,"['ASAH1', 'SGPL1', 'GAL3ST1', 'PLPP1']",0.9982792556030828,0,0,4
414,Heme Biosynthesis WP561,0.7953101787310456,0.6514511129895745,0.149197339386084,['ALAD'],0.9982792556030828,0,0,1
415,Macrophage markers WP4146,0.7953101787310456,0.6514511129895745,0.149197339386084,['CD68'],0.9982792556030828,0,0,1
416,NAD Biosynthesis II (from tryptophan) WP2485,0.7953101787310456,0.6514511129895745,0.149197339386084,['AFMID'],0.9982792556030828,0,0,1
417,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7953101787310456,0.6514511129895745,0.149197339386084,['NFKB1'],0.9982792556030828,0,0,1
418,IL-2 signaling pathway WP49,0.8009722792211139,0.7352035507230988,0.16316294486281344,"['CCND2', 'STAT1', 'SOS1', 'HRAS', 'JAK3']",0.9982792556030828,0,0,5
419,AMP-activated protein kinase (AMPK) signaling WP1403,0.807825671469918,0.7738336587853385,0.16514306486591993,"['GYS2', 'PIK3CA', 'PRKAG1', 'PIK3CD', 'PIK3R3', 'CPT1B', 'ACACB', 'ACACA', 'CAMKK2']",0.9982792556030828,0,0,9
420,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8096245855763075,0.6838322368421053,0.14441484653400677,"['SESN3', 'PTEN', 'BAX']",0.9982792556030828,0,0,3
421,Netrin-UNC5B signaling pathway WP4747,0.8103156122107579,0.7391006416360384,0.15545611889206432,"['PIK3CA', 'AGAP2', 'ALPL', 'RAC1', 'NEO1', 'RHOA']",0.9982792556030828,0,0,6
422,TGF-beta Receptor Signaling WP560,0.8103156122107579,0.7391006416360384,0.15545611889206432,"['TGFBR3', 'ZEB2', 'STAT1', 'HRAS', 'LTBP1', 'NFKB1']",0.9982792556030828,0,0,6
423,Ciliopathies WP4803,0.8104801369279834,0.8479328638068234,0.1781748143819852,"['ARL3', 'CSPP1', 'TTC21B', 'TMEM107', 'NEK1', 'BBS9', 'NEK2', 'BBS4', 'CEP78', 'PLK4', 'DNAH11', 'MKKS', 'IFT140', 'DCDC2', 'CFAP410', 'POMGNT1', 'RSPH3', 'AHI1', 'CENPF', 'RSPH1', 'TMEM17', 'BBS12', 'SPAG1', 'IFT27', 'CEP41', 'CCNQ', 'CCNO']",0.9982792556030828,0,0,27
424,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.8111209533676994,0.6513364964532343,0.1363495413497067,"['RBBP4', 'JARID2']",0.9982792556030828,0,0,2
425,NOTCH1 regulation of endothelial cell calcification WP3413,0.8111209533676994,0.6513364964532343,0.1363495413497067,"['ALPL', 'DLL3']",0.9982792556030828,0,0,2
426,SARS coronavirus and innate immunity WP4912,0.8111209533676994,0.6513364964532343,0.1363495413497067,"['STAT1', 'IFNAR1']",0.9982792556030828,0,0,2
427,Serotonin and anxiety WP3947,0.8111209533676994,0.6513364964532343,0.1363495413497067,"['PRKCB', 'CRH']",0.9982792556030828,0,0,2
428,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8139606536797321,0.7012934416685651,0.14435652204368854,"['PIK3CA', 'IKBKG', 'NFKB1', 'RHOA']",0.9982792556030828,0,0,4
429,Sleep regulation WP3591,0.8139606536797321,0.7012934416685651,0.14435652204368854,"['PER3', 'STAR', 'CRH', 'DRD1']",0.9982792556030828,0,0,4
430,Neural Crest Differentiation WP2064,0.824451673730939,0.7810152236414196,0.15076464165865136,"['ITGB1', 'GSK3B', 'PAX7', 'MPZ', 'NOTCH4', 'HDAC11', 'TCF4', 'ASCL1', 'NFKB1', 'SOX5', 'RHOB', 'DLL3']",0.9982792556030828,0,0,12
431,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8277389397843771,0.719598634386427,0.13604549322204432,"['IDI1', 'NSDHL', 'SOAT1', 'PMVK', 'LSS', 'TM7SF2']",0.9982792556030828,0,0,6
432,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8318862196392492,0.7593691614463128,0.13976918619949658,"['GSK3B', 'WNT10B', 'PORCN', 'WNT10A', 'CCND2', 'SFRP2', 'CSNK2A1', 'ROR1', 'CXXC4', 'DKK2']",0.9982792556030828,0,0,10
433,Cell Differentiation - Index WP2029,0.8321356984387818,0.5699786324786325,0.10473913236335108,['MEF2D'],0.9982792556030828,0,0,1
434,Cytosine methylation WP3585,0.8321356984387818,0.5699786324786325,0.10473913236335108,['IDH2'],0.9982792556030828,0,0,1
435,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.8321356984387818,0.5699786324786325,0.10473913236335108,['STAT1'],0.9982792556030828,0,0,1
436,Wnt signaling in kidney disease WP4150,0.8340744947596163,0.675270861516337,0.12251611998995782,"['MAPK10', 'WNT10B', 'WNT10A', 'RHOA']",0.9982792556030828,0,0,4
437,GDNF/RET signaling axis WP4830,0.8375741758988203,0.6078702181300011,0.10774223094213602,"['RET', 'IFT27']",0.9982792556030828,0,0,2
438,Proteoglycan biosynthesis WP4784,0.8375741758988203,0.6078702181300011,0.10774223094213602,"['B3GALT6', 'B4GALT7']",0.9982792556030828,0,0,2
439,Vitamin A and carotenoid metabolism WP716,0.838360762932127,0.6905460131266583,0.12174793465815144,"['RXRB', 'SDR16C5', 'CYP26B1', 'RBP4', 'LPL']",0.9982792556030828,0,0,5
440,Energy Metabolism WP1541,0.8438589588587586,0.7010967300726932,0.11902512785963273,"['NCOA1', 'GSK3B', 'MYBBP1A', 'PRKAG1', 'PPARG', 'MEF2D']",0.9982792556030828,0,0,6
441,Genotoxicity pathway WP4286,0.8498702157697479,0.7088127653345044,0.11530372682818958,"['RPS27', 'GADD45A', 'BLOC1S2', 'SEL1L', 'RAPGEF2', 'TRIAP1', 'PPM1D']",0.9982792556030828,0,0,7
442,Osteoblast differentiation WP4787,0.8504338698065189,0.7763337636603819,0.12577276532692272,"['PRKCG', 'WNT10B', 'WNT10A', 'PRKCB', 'STAT1', 'NOTCH4', 'PRKCD', 'PIK3R3', 'PIK3CD', 'DLL3', 'MAPK10', 'HEY1', 'PIK3CA', 'PPARG', 'FGF10']",0.9982792556030828,0,0,15
443,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.852336803073698,0.6511070370892681,0.10402966418579937,"['NFKBIA', 'SUPT4H1', 'NELFA', 'NFKB1']",0.9982792556030828,0,0,4
444,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8523463513925649,0.747902965384161,0.1194867121659015,"['GSK3B', 'WNT10B', 'CDK8', 'PORCN', 'WNT10A', 'CCND2', 'SFRP2', 'CSNK2A1', 'ROR1', 'CXXC4', 'DKK2']",0.9982792556030828,0,0,11
445,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8547761112639345,0.670187429810634,0.10516293136013047,"['NFKBIA', 'PIK3CA', 'STAT1', 'JAK2', 'NFKB1']",0.9982792556030828,0,0,5
446,Nuclear Receptors Meta-Pathway WP2882,0.8585945186508748,0.8393357349401483,0.12796387324438496,"['HSP90AB1', 'MGST3', 'TGFA', 'TXN', 'NR3C1', 'SLC5A3', 'CPT2', 'FTH1', 'SLC39A7', 'SLC39A1', 'SLC39A4', 'CAP2', 'SLC39A3', 'NCOA1', 'IL11', 'CBR1', 'NCOA2', 'ABCC4', 'G6PD', 'HSP90AA1', 'GPX3', 'PTGES3', 'SLC39A10', 'APOA1', 'NRG1', 'SMARCA1', 'CES4A', 'TGFBR3', 'KAT2B', 'PSMC5', 'GSTA4', 'DNAJC7', 'CDC37', 'CDK1', 'BAX', 'SQSTM1', 'SLC27A5', 'FKBP5']",0.9982792556030828,0,0,38
447,15q13.3 copy number variation syndrome WP4942,0.8606246957695168,0.569837224597172,0.08553072284822853,"['KAT2B', 'MTMR10']",0.9982792556030828,0,0,2
448,Kynurenine Pathway and links to Cellular Senescence WP5044,0.8606246957695168,0.569837224597172,0.08553072284822853,"['EIF2AK1', 'AFMID']",0.9982792556030828,0,0,2
449,Nicotine Activity on Dopaminergic Neurons WP1602,0.8606246957695168,0.569837224597172,0.08553072284822853,"['GNB1', 'PRKACA']",0.9982792556030828,0,0,2
450,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8621880884076397,0.7193213752905666,0.10666229140522226,"['PTPRT', 'PDGFRB', 'MAPK10', 'PRKCB', 'STMN1', 'RICTOR', 'JAK2', 'JAK3', 'IFNAR1']",0.9982792556030828,0,0,9
451,Autosomal recessive Osteopetrosis pathways WP4788,0.862337704160299,0.5066111476367887,0.07503332438515559,['NFKB1'],0.9982792556030828,0,0,1
452,LTF danger signal response pathway WP4478,0.862337704160299,0.5066111476367887,0.07503332438515559,['NFKB1'],0.9982792556030828,0,0,1
453,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.862337704160299,0.5066111476367887,0.07503332438515559,['GNMT'],0.9982792556030828,0,0,1
454,Nanoparticle triggered regulated necrosis WP2513,0.862337704160299,0.5066111476367887,0.07503332438515559,['PARP1'],0.9982792556030828,0,0,1
455,Trans-sulfuration pathway WP2333,0.862337704160299,0.5066111476367887,0.07503332438515559,['GOT1'],0.9982792556030828,0,0,1
456,Valproic acid pathway WP3871,0.862337704160299,0.5066111476367887,0.07503332438515559,['IVD'],0.9982792556030828,0,0,1
457,Amino Acid metabolism WP3925,0.8635335161531696,0.7368510398882508,0.1081126766899904,"['WARS', 'GOT1', 'MDH2', 'MARS2', 'GSS', 'ODC1', 'PYCR1', 'DLD', 'FTCD', 'GLS', 'SRM']",0.9982792556030828,0,0,11
458,Type 2 papillary renal cell carcinoma WP4241,0.8688624698398779,0.6286096833123419,0.08836393272877609,"['TGFA', 'ELOB', 'ELOC', 'RBX1']",0.9982792556030828,0,0,4
459,16p11.2 distal deletion syndrome WP4950,0.87126818493994,0.594508009153318,0.08192644068862961,"['CD81', 'JAK2', 'RAB5A']",0.9982792556030828,0,0,3
460,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8736508216809377,0.7068681381128816,0.09547986080398212,"['ITGB1', 'RYR2', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGAV', 'DSG2', 'SLC8A1', 'ACTG1']",0.9982792556030828,0,0,9
461,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.8806404450537798,0.5362787008917346,0.06816416426561445,"['PTEN', 'ZFX']",0.9982792556030828,0,0,2
462,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.8806404450537798,0.5362787008917346,0.06816416426561445,"['BECN1', 'MAP1LC3A']",0.9982792556030828,0,0,2
463,miRNA targets in ECM and membrane receptors WP2911,0.8806404450537798,0.5362787008917346,0.06816416426561445,"['COL5A1', 'LAMC1']",0.9982792556030828,0,0,2
464,Alanine and aspartate metabolism WP106,0.8871071913355918,0.4559171597633136,0.05461406896921592,['GOT1'],0.9982792556030828,0,0,1
465,Biogenic Amine Synthesis WP550,0.8871071913355918,0.4559171597633136,0.05461406896921592,['AANAT'],0.9982792556030828,0,0,1
466,Biomarkers for urea cycle disorders WP4583,0.8871071913355918,0.4559171597633136,0.05461406896921592,['GOT1'],0.9982792556030828,0,0,1
467,Cells and molecules involved in local acute inflammatory response  WP4493,0.8871071913355918,0.4559171597633136,0.05461406896921592,['ITGB1'],0.9982792556030828,0,0,1
468,Neuroinflammation WP4919,0.8871071913355918,0.4559171597633136,0.05461406896921592,['NFKBIA'],0.9982792556030828,0,0,1
469,Ethanol effects on histone modifications WP3996,0.8874911923390596,0.5696957236842105,0.0679969912184789,"['KAT2B', 'ACSS2', 'EHMT2']",0.9982792556030828,0,0,3
470,T-cell receptor (TCR) signaling pathway WP69,0.8887074892723579,0.7007025285957037,0.08267388106920873,"['VAV3', 'CDC42', 'NFKBIA', 'ZAP70', 'DBNL', 'PRKCD', 'IKBKG', 'SOS1', 'HRAS', 'NFKB1']",0.9982792556030828,0,0,10
471,Oxysterols derived from cholesterol WP4545,0.897177423736558,0.587969302295959,0.06379563337755587,"['ACOT8', 'ACOT7', 'ACOT13', 'SLC27A5']",0.9982792556030828,0,0,4
472,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8979671040647922,0.5064489020424567,0.05450496462600257,"['NFKB1', 'BCL2L2']",0.9982792556030828,0,0,2
473,Endothelin Pathways WP2197,0.901859421781949,0.5468684210526316,0.056489660982613904,"['RIIAD1', 'GNB5', 'CALM2']",0.9982792556030828,0,0,3
474,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.901859421781949,0.5468684210526316,0.056489660982613904,"['TGFBR3', 'TGFA', 'HRAS']",0.9982792556030828,0,0,3
475,Glycerophospholipid Biosynthetic Pathway WP2533,0.901859421781949,0.5468684210526316,0.056489660982613904,"['PIK3CA', 'PIK3CD', 'CDIPT']",0.9982792556030828,0,0,3
476,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9034443701165024,0.6719582437295352,0.06823113891817491,"['MAPK10', 'GSK3B', 'GADD45A', 'AKT3', 'CYCS', 'BAX', 'BRAF', 'RAC1', 'RHOA']",0.9982792556030828,0,0,9
477,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9071189603455904,0.5994681403970756,0.05843716108697816,"['BECN1', 'MAP1LC3A', 'WIPI2', 'PLA2G6', 'ACACA']",0.9982792556030828,0,0,5
478,Disorders of Folate Metabolism and Transport WP4259,0.9074210565130006,0.41444026059410677,0.04026233531918286,['FTCD'],0.9982792556030828,0,0,1
479,Drug Induction of Bile Acid Pathway WP2289,0.9074210565130006,0.41444026059410677,0.04026233531918286,['ABCC4'],0.9982792556030828,0,0,1
480,Iron metabolism in placenta WP2007,0.9074210565130006,0.41444026059410677,0.04026233531918286,['FTH1'],0.9982792556030828,0,0,1
481,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.9074210565130006,0.41444026059410677,0.04026233531918286,['ITGAV'],0.9982792556030828,0,0,1
482,22q11.2 copy number variation syndrome WP4657,0.9091336398805565,0.7046008172245796,0.0671225123940474,"['RANBP1', 'EMC10', 'RBX1', 'CDC42', 'AIFM3', 'CYP26B1', 'MRPL40', 'HIRIP3', 'HIST1H4C', 'TNPO1', 'HIST1H4E', 'RAN', 'FGF10']",0.9982792556030828,0,0,13
483,Differentiation of white and brown adipocyte WP2895,0.912924205413015,0.4797590820194188,0.04370721286387482,"['CIDEA', 'PPARG']",0.9982792556030828,0,0,2
484,Eicosanoid Synthesis WP167,0.912924205413015,0.4797590820194188,0.04370721286387482,"['PLA2G6', 'PTGES']",0.9982792556030828,0,0,2
485,Glycerolipids and Glycerophospholipids WP4722,0.912924205413015,0.4797590820194188,0.04370721286387482,"['DGAT2', 'CDIPT']",0.9982792556030828,0,0,2
486,Kallmann's Syndrome WP5074,0.912924205413015,0.4797590820194188,0.04370721286387482,"['PIK3CA', 'ASCL1']",0.9982792556030828,0,0,2
487,Purinergic signaling WP4900,0.912924205413015,0.4797590820194188,0.04370721286387482,"['PANX1', 'P2RX5']",0.9982792556030828,0,0,2
488,Wnt signaling pathway and pluripotency WP399,0.9129350578544678,0.6915877702558791,0.06299709751341624,"['PRKCG', 'MAPK10', 'MAP2K4', 'WNT10B', 'GSK3B', 'PPP2CB', 'WNT10A', 'CCND2', 'PRKCB', 'PRKCD', 'RHOA', 'PAFAH1B1']",0.9982792556030828,0,0,12
489,Heart Development WP1591,0.9145485099080501,0.5257970647773279,0.046966700447019075,"['HEY1', 'VEGFC', 'FGF10']",0.9982792556030828,0,0,3
490,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9145485099080501,0.5257970647773279,0.046966700447019075,"['PIK3CA', 'BAX', 'BRAF']",0.9982792556030828,0,0,3
491,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.918134034072546,0.639186103644614,0.05459409471101,"['ITGB1', 'LAMA5', 'INF2', 'YWHAQ', 'CTSL', 'MYH9', 'ITGAV', 'CD2AP']",0.9982792556030828,0,0,8
492,IL-5 signaling pathway WP127,0.9199608519741033,0.5522550280694407,0.046071412952650236,"['GSK3B', 'STAT1', 'JAK2', 'SOS1']",0.9982792556030828,0,0,4
493,Oxidation by Cytochrome P450 WP43,0.9199608519741033,0.5522550280694407,0.046071412952650236,"['CYB5R1', 'CYP26B1', 'CYB5R3', 'CYP24A1']",0.9982792556030828,0,0,4
494,Omega-3/Omega-6 FA synthesis WP4723,0.9240805745392634,0.379876177953101,0.029993507024117055,['PLA2G6'],0.9982792556030828,0,0,1
495,Prion disease pathway WP3995,0.9257248974832013,0.5062865497076023,0.039074272149266336,"['PDIA3', 'NFKB1', 'HSP90B1']",0.9982792556030828,0,0,3
496,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.9258033577735029,0.4557382439986846,0.03513442145106043,"['PLA2G6', 'PTGES']",0.9982792556030828,0,0,2
497,NAD+ biosynthetic pathways WP3645,0.9258033577735029,0.4557382439986846,0.03513442145106043,"['PARP1', 'TNKS']",0.9982792556030828,0,0,2
498,MECP2 and Associated Rett Syndrome WP3584,0.9258506932513216,0.6281202067829347,0.04839182272229997,"['PRPF38A', 'CAMK2A', 'SP3', 'PTEN', 'E2F1', 'NREP', 'IGF1R', 'FKBP5']",0.9982792556030828,0,0,8
499,Lung fibrosis WP3624,0.9295608276889886,0.5359735207014691,0.03914913137810349,"['TERT', 'ELN', 'FAM13A', 'TGFA']",0.9982792556030828,0,0,4
500,Vitamin B12 metabolism WP1533,0.9295608276889886,0.5359735207014691,0.03914913137810349,"['CUBN', 'APOA1', 'NFKB1', 'SOD1']",0.9982792556030828,0,0,4
501,Metapathway biotransformation Phase I and II WP702,0.9310419331426436,0.7001092729536733,0.05002348088252259,"['GAL3ST1', 'GPX4', 'GPX3', 'NAA20', 'MGST3', 'GSS', 'AKR1A1', 'KCNAB3', 'HS3ST1', 'NAA80', 'GSTZ1', 'AKR7A2', 'CYP26B1', 'CYP24A1', 'GSTA4', 'SULT4A1']",0.9982792556030828,0,0,16
502,p53 transcriptional gene network WP4963,0.9326210557465485,0.6014741342879161,0.04195662061621049,"['SIVA1', 'GADD45A', 'SESN1', 'PTEN', 'BAX', 'FANCC', 'ISG15']",0.9982792556030828,0,0,7
503,One-carbon metabolism and related pathways WP3940,0.9347369719647622,0.5554841921032772,0.03748968516003407,"['GPX4', 'GPX3', 'GSS', 'SOD1', 'GNMT']",0.9982792556030828,0,0,5
504,Fluoropyrimidine Activity WP1601,0.935544543036846,0.48816964285714287,0.03252504459624398,"['ABCC4', 'ERCC2', 'GGH']",0.9982792556030828,0,0,3
505,The influence of laminopathies on Wnt signaling WP4844,0.935544543036846,0.48816964285714287,0.03252504459624398,"['GSK3B', 'WNT10B', 'PPARG']",0.9982792556030828,0,0,3
506,Sphingolipid Metabolism (general overview) WP4725,0.9368679530426391,0.434005104837068,0.028302745355798194,"['ASAH1', 'SGPL1']",0.9982792556030828,0,0,2
507,Kennedy pathway from sphingolipids WP3933,0.9377429624040521,0.35062964648763467,0.02253826148078754,['SGPL1'],0.9982792556030828,0,0,1
508,Gastric Cancer Network 1 WP2361,0.9463538821735894,0.4142477055992347,0.02284107882380096,"['CENPF', 'MCM4']",0.9982792556030828,0,0,2
509,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.9463538821735894,0.4142477055992347,0.02284107882380096,"['CYP24A1', 'PPARG']",0.9982792556030828,0,0,2
510,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.9463538821735894,0.4142477055992347,0.02284107882380096,"['ASCL1', 'SOX5']",0.9982792556030828,0,0,2
511,Signal Transduction of S1P Receptor WP26,0.9463538821735894,0.4142477055992347,0.02284107882380096,"['ASAH1', 'AKT3']",0.9982792556030828,0,0,2
512,Sphingolipid Metabolism (integrated pathway) WP4726,0.9463538821735894,0.4142477055992347,0.02284107882380096,"['ASAH1', 'SGPL1']",0.9982792556030828,0,0,2
513,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.9463538821735894,0.4142477055992347,0.02284107882380096,"['STAT1', 'IFNAR1']",0.9982792556030828,0,0,2
514,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9463538821735894,0.4142477055992347,0.02284107882380096,"['GSK3B', 'ZBTB16']",0.9982792556030828,0,0,2
515,Biomarkers for pyrimidine metabolism disorders WP4584,0.9489472715659847,0.3255611909458063,0.01706007185817402,['TK2'],0.9982792556030828,0,0,1
516,miRNAs involved in DNA damage response WP1545,0.9489472715659847,0.3255611909458063,0.01706007185817402,['E2F1'],0.9982792556030828,0,0,1
517,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9489472715659847,0.3255611909458063,0.01706007185817402,['DLD'],0.9982792556030828,0,0,1
518,Tryptophan catabolism leading to NAD+ production WP4210,0.9489472715659847,0.3255611909458063,0.01706007185817402,['AFMID'],0.9982792556030828,0,0,1
519,MTHFR deficiency WP4288,0.9544709053048313,0.3962083410777347,0.01846256298624724,"['EHMT2', 'CYCS']",0.9982792556030828,0,0,2
520,Pre-implantation embryo WP3527,0.9582531688386426,0.4408319185059423,0.018798513566722665,"['BATF3', 'DDIT3', 'NR3C2']",0.9982792556030828,0,0,3
521,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9614044187248734,0.3796722569330264,0.014943948402038689,"['THRA', 'STAT1']",0.9982792556030828,0,0,2
522,Toll-like Receptor Signaling related to MyD88 WP3858,0.9614044187248734,0.3796722569330264,0.014943948402038689,"['IKBKG', 'NFKB1']",0.9982792556030828,0,0,2
523,"GPCRs, Other WP117",0.9624615750115111,0.5253286390922216,0.02009967033850851,"['CCKBR', 'ADGRF5', 'GPR61', 'ADRA1D', 'CELSR3', 'MCHR2']",0.9982792556030828,0,0,6
524,Interleukin-11 Signaling Pathway WP2332,0.9636428401362841,0.4670902202985125,0.017298476495000152,"['IL11', 'STAT1', 'JAK2', 'HRAS']",0.9982792556030828,0,0,4
525,Peptide GPCRs WP24,0.9636428401362841,0.4670902202985125,0.017298476495000152,"['CCKBR', 'TACR2', 'SSTR1', 'FPR2']",0.9982792556030828,0,0,4
526,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9636428401362841,0.4670902202985125,0.017298476495000152,"['MAP2K4', 'HSP90AA1', 'TRAF5', 'BAX']",0.9982792556030828,0,0,4
527,"GPCRs, Class B Secretin-like WP334",0.9656706566341823,0.2848249506903353,0.009949629948652236,['ADGRE5'],0.9982792556030828,0,0,1
528,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9656706566341823,0.2848249506903353,0.009949629948652236,['CPT2'],0.9982792556030828,0,0,1
529,Pyrimidine metabolism and related diseases WP4225,0.9656706566341823,0.2848249506903353,0.009949629948652236,['TK2'],0.9982792556030828,0,0,1
530,Differentiation Pathway WP2848,0.9689585772216589,0.41405502392344495,0.013056569303993452,"['IL11', 'NT5E', 'FGF10']",0.9982792556030828,0,0,3
531,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9690090854863581,0.484361211883518,0.015248316254805983,"['GSK3B', 'KAT2B', 'WNT10B', 'E2F1', 'PPARG']",0.9982792556030828,0,0,5
532,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.9718497704068129,0.2680512047027884,0.007653945802608864,['NFKB1'],0.9982792556030828,0,0,1
533,Male infertility WP4673,0.972991170892433,0.5933039748683889,0.01624482358511561,"['PRMT6', 'CYP26B1', 'DDX4', 'UBE2B', 'PARP1', 'CAT', 'ERCC2', 'PEX10', 'HORMAD1', 'CDC42BPA', 'CLOCK', 'SOX5']",0.9982792556030828,0,0,12
534,Hedgehog Signaling Pathway WP4249,0.9732818697769777,0.4018479102167183,0.010882663188975643,"['CCND2', 'SMURF2', 'PRKACA']",0.9982792556030828,0,0,3
535,TYROBP causal network in microglia WP3945,0.975938434285482,0.43363261724564783,0.01056145810452933,"['ABCC4', 'CD84', 'MAF', 'SFT2D2']",0.9982792556030828,0,0,4
536,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9769168969106946,0.2531412082694134,0.005911781307674846,['BAX'],0.9982792556030828,0,0,1
537,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.9769168969106946,0.2531412082694134,0.005911781307674846,['HRAS'],0.9982792556030828,0,0,1
538,Ectoderm Differentiation WP2858,0.9781492509010415,0.6089150075485941,0.013452766755995977,"['ABCC4', 'EDA', 'TSC22D1', 'ZBTB16', 'HMGB2', 'STC1', 'JAKMIP1', 'CDH8', 'AHI1', 'PLCXD3', 'ARHGEF9', 'NF2', 'ANKS1B', 'LY6E', 'CAP2']",0.9982792556030828,0,0,15
539,Kit receptor signaling pathway WP304,0.9816011228254767,0.446243013334366,0.008286840620514867,"['PRKCB', 'STAT1', 'JAK2', 'SOS1', 'HRAS']",0.9982792556030828,0,0,5
540,Neovascularisation processes WP4331,0.983355232058717,0.31409813015228655,0.0052720895834335955,"['NOTCH4', 'NFKB1']",0.9982792556030828,0,0,2
541,Angiogenesis WP1539,0.9844794333371164,0.22779421433267588,0.0035632189663700165,['PIK3CA'],0.9982792556030828,0,0,1
542,Hepatitis C and Hepatocellular Carcinoma WP3646,0.98549531849673,0.3594442520775623,0.005251805023545704,"['RAC1', 'SOS1', 'NFKB1']",0.9982792556030828,0,0,3
543,Vitamin D Receptor Pathway WP2877,0.9863598037666602,0.5628225679710829,0.007729849274726468,"['CDKN2D', 'G6PD', 'GADD45A', 'TPM1', 'EFNA5', 'SLC8A1', 'CYP24A1', 'ADGRE5', 'CREG2', 'S100A6', 'CLPTM1L', 'HLA-DRB1', 'CD200']",0.9982792556030828,0,0,13
544,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9872734801668213,0.21693121693121692,0.002778497478367181,['FPR2'],0.9982792556030828,0,0,1
545,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.9872734801668213,0.21693121693121692,0.002778497478367181,['ABCC4'],0.9982792556030828,0,0,1
546,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9895645903256458,0.20705576474807244,0.0021720647378885814,['PRKACA'],0.9982792556030828,0,0,1
547,Glucocorticoid Receptor Pathway WP2880,0.9906379191843387,0.40625293896360387,0.003821288494329461,"['TGFBR3', 'IL11', 'HSP90AA1', 'PTGES3', 'NR3C1']",0.9982792556030828,0,0,5
548,Ovarian infertility WP34,0.9929837370677441,0.18977372342756957,0.0013361953911261147,['CCND2'],0.9982792556030828,0,0,1
549,Hematopoietic Stem Cell Differentiation WP2849,0.9950374667659481,0.25289561182359604,0.0012581272158718655,"['GYPA', 'ZNF835']",0.9982792556030828,0,0,2
550,One-carbon metabolism WP241,0.9961317847793129,0.1686512284802883,0.0006536442840042426,['FTCD'],0.9982792556030828,0,0,1
551,Allograft Rejection WP2328,0.9965184660733196,0.2904255319148936,0.001012890573879832,"['COL5A1', 'STAT1', 'HLA-DRB1']",0.9982792556030828,0,0,3
552,Trans-sulfuration and one-carbon metabolism WP2525,0.9968280809865484,0.16261622992392225,0.0005166252922237434,['GSS'],0.9982792556030828,0,0,1
553,"GPCRs, Class A Rhodopsin-like WP455",0.9981108335796153,0.46568366198851185,0.0008805859856325885,"['MAS1', 'CCKBR', 'HTR1E', 'GPR22', 'RHO', 'RRH', 'NMUR2', 'ADRA1D', 'FPR2', 'DRD1', 'SSTR1', 'HTR5A']",0.9982792556030828,0,0,12
554,Complement and Coagulation Cascades WP558,0.9982792556030828,0.21667371322090165,0.00037316122768558106,"['F8', 'KLKB1']",0.9982792556030828,0,0,2
